{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:06:50Z","timestamp":1793326010494,"version":"4.5.0"},"reference-count":653,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["pharmrev.aspetjournals.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reviews"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1124\/pr.118.015578","type":"journal-article","created":{"date-parts":[[2019,12,18]],"date-time":"2019-12-18T18:15:13Z","timestamp":1576692913000},"page":"253-319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":296,"title":["Organic Cation Transporters in Health and Disease"],"prefix":"10.1016","volume":"72","author":[{"given":"Hermann","family":"Koepsell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1124\/pr.118.015578_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1126\/science.1088196","article-title":"Structure and mechanism of the lactose permease of Escherichia coli","volume":"301","author":"Abramson","year":"2003","journal-title":"Science"},{"key":"10.1124\/pr.118.015578_bib2","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/tpj.2010.54","article-title":"Genotype-dependent effects of inhibitors of the organic cation transporter, OCT1: predictions of metformin interactions","volume":"11","author":"Ahlin","year":"2011","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pr.118.015578_bib3","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1021\/jm8003152","article-title":"Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1","volume":"51","author":"Ahlin","year":"2008","journal-title":"J Med Chem"},{"key":"10.1124\/pr.118.015578_bib4","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1095\/biolreprod.112.105064","article-title":"Organic cation transporter 3 (OCT3\/SLC22A3) and multidrug and toxin extrusion 1 (MATE1\/SLC47A1) transporter in the placenta and fetal tissues: expression profile and fetus protective role at different stages of gestation","volume":"88","author":"Ahmadimoghaddam","year":"2013","journal-title":"Biol Reprod"},{"key":"10.1124\/pr.118.015578_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/bph.14563","article-title":"Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib","volume":"176","author":"Al-Abdulla","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib6","first-page":"83","article-title":"Management of treatment resistant obsessive-compulsive disorder: algorithms for pharmacotherapy","volume":"44","author":"Albert","year":"2002","journal-title":"Panminerva Med"},{"key":"10.1124\/pr.118.015578_bib7","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/jpet.102.038315","article-title":"Transporter gene expression in lactating and nonlactating human mammary epithelial cells using real-time reverse transcription-polymerase chain reaction","volume":"303","author":"Alcorn","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.ymgme.2008.02.002","article-title":"Cardiomyopathy and carnitine deficiency","volume":"94","author":"Amat di San Filippo","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1124\/pr.118.015578_bib9","doi-asserted-by":"crossref","first-page":"12287","DOI":"10.1016\/S0021-9258(19)38343-7","article-title":"UhpT, the sugar phosphate antiporter of Escherichia coli, functions as a monomer","volume":"265","author":"Ambudkar","year":"1990","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib10","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.neuropharm.2006.01.005","article-title":"Differential pharmacological in vitro properties of organic cation transporters and regional distribution in rat brain","volume":"50","author":"Amphoux","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1124\/pr.118.015578_bib11","doi-asserted-by":"crossref","first-page":"F165","DOI":"10.1152\/ajprenal.90257.2008","article-title":"Kidney-specific expression of human organic cation transporter 2 (OCT2\/SLC22A2) is regulated by DNA methylation","volume":"295","author":"Aoki","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1006\/bbrc.2000.3561","article-title":"Molecular cloning of a human, hemicholinium-3-sensitive choline transporter","volume":"276","author":"Apparsundaram","year":"2000","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib13","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1093\/jnci\/djk196","article-title":"Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non-small-cell lung cancer: an individual patient data meta-analysis","volume":"99","author":"Ardizzoni","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"10.1124\/pr.118.015578_bib14","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0003-9861(92)90702-X","article-title":"Possible mechanism of inhibition of nitrite-induced oxidation of oxyhemoglobin by ergothioneine and uric acid","volume":"294","author":"Arduini","year":"1992","journal-title":"Arch Biochem Biophys"},{"key":"10.1124\/pr.118.015578_bib15","doi-asserted-by":"crossref","first-page":"F454","DOI":"10.1152\/ajprenal.2001.281.3.F454","article-title":"Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1","volume":"281","author":"Arndt","year":"2001","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib16","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1111\/dom.13395","article-title":"Mapping of biguanide transporters in human fat cells and their impact on lipolysis","volume":"20","author":"Arner","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pr.118.015578_bib17","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1124\/jpet.106.118695","article-title":"Characterization of the Basal promoter element of human organic cation transporter 2 gene","volume":"321","author":"Asaka","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1124\/mol.106.032938","article-title":"Identification of essential histidine and cysteine residues of the H+\/organic cation antiporter multidrug and toxin extrusion (MATE)","volume":"71","author":"Asaka","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib19","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.112.191577","article-title":"Molecular determinants of ligand selectivity for the human multidrug and toxin extruder proteins MATE1 and MATE2-K","volume":"341","author":"Astorga","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib20","doi-asserted-by":"crossref","first-page":"6628","DOI":"10.1021\/bi010138+","article-title":"High-yield expression and functional analysis of Escherichia coli glycerol-3-phosphate transporter","volume":"40","author":"Auer","year":"2001","journal-title":"Biochemistry"},{"key":"10.1124\/pr.118.015578_bib21","doi-asserted-by":"crossref","first-page":"H1904","DOI":"10.1152\/ajpheart.00308.2015","article-title":"Organic cation transporter 3 contributes to norepinephrine uptake into perivascular adipose tissue","volume":"309","author":"Ayala-Lopez","year":"2015","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1124\/pr.118.015578_bib22","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0022-3565(24)38743-9","article-title":"Regulation of ornithine decarboxylase activity and polyamine transport by agmatine in rat pulmonary artery endothelial cells","volume":"296","author":"Bab\u00e1l","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib23","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1111\/j.1572-0241.2006.00564.x","article-title":"Contribution of OCTN variants within the IBD5 locus to pediatric onset Crohn\u2019s disease","volume":"101","author":"Babusukumar","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/pr.118.015578_bib24","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.bbamem.2009.09.019","article-title":"Substrate discrimination by ergothioneine transporter SLC22A4 and carnitine transporter SLC22A5: gain-of-function by interchange of selected amino acids","volume":"1788","author":"Bacher","year":"2009","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib25","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/j.1463-1326.2009.01076.x","article-title":"Interaction of beta-blockers with the renal uptake transporter OCT2","volume":"11","author":"Bachmakov","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pr.118.015578_bib26","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/db07-1515","article-title":"Interaction of oral antidiabetic drugs with hepatic uptake transporters: focus on organic anion transporting polypeptides and organic cation transporter 1","volume":"57","author":"Bachmakov","year":"2008","journal-title":"Diabetes"},{"key":"10.1124\/pr.118.015578_bib27","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/mp.2011.87","article-title":"Organic cation transporter 2 controls brain norepinephrine and serotonin clearance and antidepressant response","volume":"17","author":"Bacq","year":"2012","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.118.015578_bib28","doi-asserted-by":"crossref","first-page":"18976","DOI":"10.1073\/pnas.0800466105","article-title":"Organic cation transporter 3: keeping the brake on extracellular serotonin in serotonin-transporter-deficient mice","volume":"105","author":"Baganz","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib29","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1007\/s00204-017-2008-8","article-title":"Multiple drug transporters mediate the placental transport of sulpiride","volume":"91","author":"Bai","year":"2017","journal-title":"Arch Toxicol"},{"key":"10.1124\/pr.118.015578_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/09687688.2018.1448123","article-title":"Structural biology of solute carrier (SLC) membrane transport proteins","volume":"34","author":"Bai","year":"2017","journal-title":"Mol Membr Biol"},{"key":"10.1124\/pr.118.015578_bib31","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1007\/s00125-008-1053-5","article-title":"Metformin and the intestine","volume":"51","author":"Bailey","year":"2008","journal-title":"Diabetologia"},{"key":"10.1124\/pr.118.015578_bib32","doi-asserted-by":"crossref","first-page":"227","DOI":"10.2174\/1389200054021807","article-title":"Trimethylamine: metabolic, pharmacokinetic and safety aspects","volume":"6","author":"Bain","year":"2005","journal-title":"Curr Drug Metab"},{"key":"10.1124\/pr.118.015578_bib33","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.bcp.2006.06.007","article-title":"Expression of transporters potentially involved in the targeting of cytostatic bile acid derivatives to colon cancer and polyps","volume":"72","author":"Ballestero","year":"2006","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib34","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2217\/pgs-2017-0002","article-title":"OCT1 genetic variants are associated with postoperative morphine-related adverse effects in children","volume":"18","author":"Balyan","year":"2017","journal-title":"Pharmacogenomics"},{"key":"10.1124\/pr.118.015578_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1146\/annurev.mi.39.100185.001023","article-title":"Bacterial reduction of trimethylamine oxide","volume":"39","author":"Barrett","year":"1985","journal-title":"Annu Rev Microbiol"},{"key":"10.1124\/pr.118.015578_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1002\/art.20877","article-title":"Investigation of the SLC22A4 gene (associated with rheumatoid arthritis in a Japanese population) in a United Kingdom population of rheumatoid arthritis patients","volume":"52","author":"Barton","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1124\/pr.118.015578_bib37","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/nature24277","article-title":"Genetic effects on gene expression across human tissues","volume":"550","author":"Battle","year":"2017","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib38","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1073\/pnas.0711496105","article-title":"Role of GSK3 beta in behavioral abnormalities induced by serotonin deficiency","volume":"105","author":"Beaulieu","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib39","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/tpj.2009.15","article-title":"Genetic variation in the organic cation transporter 1 is associated with metformin response in patients with diabetes mellitus","volume":"9","author":"Becker","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pr.118.015578_bib40","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2337\/db08-1028","article-title":"Genetic variation in the multidrug and toxin extrusion 1 transporter protein influences the glucose-lowering effect of metformin in patients with diabetes: a preliminary study","volume":"58","author":"Becker","year":"2009","journal-title":"Diabetes"},{"key":"10.1124\/pr.118.015578_bib41","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/FPC.0b013e328333bb11","article-title":"Interaction between polymorphisms in the OCT1 and MATE1 transporter and metformin response","volume":"20","author":"Becker","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1124\/mol.63.3.489","article-title":"Influence of molecular structure on substrate binding to the human organic cation transporter, hOCT1","volume":"63","author":"Bednarczyk","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib43","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1124\/jpet.113.203257","article-title":"Substrate-dependent ligand inhibition of the human organic cation transporter OCT2","volume":"346","author":"Belzer","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib44","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12931-018-0760-9","article-title":"Expression of MATE1, P-gp, OCTN1 and OCTN2, in epithelial and immune cells in the lung of COPD and healthy individuals","volume":"19","author":"Berg","year":"2018","journal-title":"Respir Res"},{"key":"10.1124\/pr.118.015578_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1021\/mp500532x","article-title":"Expression of drug transporters and drug metabolizing enzymes in the bladder urothelium in man and affinity of the bladder spasmolytic trospium chloride to transporters likely involved in its pharmacokinetics","volume":"12","author":"Bexten","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib46","doi-asserted-by":"crossref","first-page":"C1521","DOI":"10.1152\/ajpcell.00622.2005","article-title":"Characterization of regulatory mechanisms and states of human organic cation transporter 2","volume":"290","author":"Biermann","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/pr.118.015578_bib47","article-title":"Imatinib uptake into cells is not mediated by organic cation transporters OCT1, OCT2, or OCT3, but is influenced by extracellular pH","author":"Blanc Mettral","year":"2019","journal-title":"Drug Metab Lett"},{"key":"10.1124\/pr.118.015578_bib48","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/jpm8040042","article-title":"Impact of promoter polymorphisms on the transcriptional regulation of the organic cation transporter OCT1 (SLC22A1)","volume":"8","author":"Bokelmann","year":"2018","journal-title":"J Pers Med"},{"key":"10.1124\/pr.118.015578_bib49","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.placenta.2003.10.017","article-title":"Norepinephrine transporter (NET), serotonin transporter (SERT), vesicular monoamine transporter (VMAT2) and organic cation transporters (OCT1, 2 and EMT) in human placenta from pre-eclamptic and normotensive pregnancies","volume":"25","author":"Bottalico","year":"2004","journal-title":"Placenta"},{"key":"10.1124\/pr.118.015578_bib50","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/mrd.20697","article-title":"The organic cation transporters (OCT1, OCT2, EMT) and the plasma membrane monoamine transporter (PMAT) show differential distribution and cyclic expression pattern in human endometrium and early pregnancy decidua","volume":"74","author":"Bottalico","year":"2007","journal-title":"Mol Reprod Dev"},{"key":"10.1124\/pr.118.015578_bib51","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.diabet.2010.11.002","article-title":"Metformin and digestive disorders","volume":"37","author":"Bouchoucha","year":"2011","journal-title":"Diabetes Metab"},{"key":"10.1124\/pr.118.015578_bib52","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1124\/jpet.105.091223","article-title":"Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3)","volume":"315","author":"Bourdet","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1146\/annurev.physiol.59.1.601","article-title":"Osmoreceptors in the central nervous system","volume":"59","author":"Bourque","year":"1997","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/pr.118.015578_bib54","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1124\/dmd.113.055095","article-title":"Common drugs inhibit human organic cation transporter 1 (OCT1)-mediated neurotransmitter uptake","volume":"42","author":"Boxberger","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib55","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.bcp.2018.08.028","article-title":"Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel","volume":"156","author":"Boxberger","year":"2018","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib56","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1096\/fj.11-180679","article-title":"The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization","volume":"26","author":"Brast","year":"2012","journal-title":"FASEB J"},{"key":"10.1124\/pr.118.015578_bib57","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0021-9150(98)00333-5","article-title":"Sequence polymorphisms in the apolipoprotein(a) gene and their association with lipoprotein(a) levels and myocardial infarction: The ECTIM Study","volume":"144","author":"Brazier","year":"1999","journal-title":"Atherosclerosis"},{"key":"10.1124\/pr.118.015578_bib58","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1111\/dom.13362","article-title":"Metformin targets brown adipose tissue in vivo and reduces oxygen consumption in vitro","volume":"20","author":"Breining","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1124\/pr.118.015578_bib59","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1183\/09031936.93.06020204","article-title":"A comparison of the cardiovascular and metabolic effects of formoterol, salbutamol and fenoterol","volume":"6","author":"Bremner","year":"1993","journal-title":"Eur Respir J"},{"key":"10.1124\/pr.118.015578_bib60","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1097\/MOL.0000000000000036","article-title":"Metaorganismal nutrient metabolism as a basis of cardiovascular disease","volume":"25","author":"Brown","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1124\/pr.118.015578_bib61","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.lfs.2012.04.007","article-title":"Does bladder outlet obstruction alter the non-neuronal cholinergic system of the human urothelium?","volume":"91","author":"Bschleipfer","year":"2012","journal-title":"Life Sci"},{"key":"10.1124\/pr.118.015578_bib62","doi-asserted-by":"crossref","first-page":"29413","DOI":"10.1074\/jbc.M004645200","article-title":"Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat","volume":"275","author":"Budiman","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib64","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1111\/j.1476-5381.2009.00569.x","article-title":"Differential transport of platinum compounds by the human organic cation transporter hOCT2 (hSLC22A2)","volume":"159","author":"Burger","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib65","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1124\/mol.54.2.342","article-title":"Human neurons express the polyspecific cation transporter hOCT2, which translocates monoamine neurotransmitters, amantadine, and memantine","volume":"54","author":"Busch","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0014-5793(96)01030-7","article-title":"Monoamine neurotransmitter transport mediated by the polyspecific cation transporter rOCT1","volume":"395","author":"Busch","year":"1996","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.118.015578_bib67","doi-asserted-by":"crossref","first-page":"32599","DOI":"10.1074\/jbc.271.51.32599","article-title":"Electrogenic properties and substrate specificity of the polyspecific rat cation transporter rOCT1","volume":"271","author":"Busch","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib68","doi-asserted-by":"crossref","first-page":"2724","DOI":"10.1111\/bph.14694","article-title":"Efficacious dose of metformin for breast cancer therapy is determined by cation transporter expression in tumours","volume":"176","author":"Cai","year":"2019","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib69","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/ijc.29965","article-title":"Cation-selective transporters are critical to the AMPK-mediated antiproliferative effects of metformin in human breast cancer cells","volume":"138","author":"Cai","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1124\/pr.118.015578_bib70","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0009-9236(01)51508-8","article-title":"Ethnicity influences morphine pharmacokinetics and pharmacodynamics","volume":"70","author":"Cepeda","year":"2001","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib71","doi-asserted-by":"crossref","first-page":"F293","DOI":"10.1152\/ajprenal.00251.2002","article-title":"Regulation of human organic cation transporter hOCT2 by PKA, PI3K, and calmodulin-dependent kinases","volume":"284","author":"\u00c7etinkaya","year":"2003","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib72","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1093\/jac\/dkz101","article-title":"Role of transporters in the disposition of a novel \u03b2-lactamase inhibitor: relebactam (MK-7655)","volume":"74","author":"Chan","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"10.1124\/pr.118.015578_bib73","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jhep.2008.07.037","article-title":"Sustained JNK1 activation is associated with altered histone H3 methylations in human liver cancer","volume":"50","author":"Chang","year":"2009","journal-title":"J Hepatol"},{"key":"10.1124\/pr.118.015578_bib74","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1002\/cpt.1296","article-title":"Abemaciclib inhibits renal tubular secretion without changing glomerular filtration rate","volume":"105","author":"Chappell","year":"2019","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl 14","key":"10.1124\/pr.118.015578_bib75","first-page":"11","article-title":"Monoamine dysfunction and the pathophysiology and treatment of depression","volume":"59","author":"Charney","year":"1998","journal-title":"J Clin Psychiatry"},{"key":"10.1124\/pr.118.015578_bib76","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1021\/acs.jmedchem.6b01317","article-title":"Discovery of competitive and noncompetitive ligands of the organic cation transporter 1 (OCT1; SLC22A1)","volume":"60","author":"Chen","year":"2017","journal-title":"J Med Chem"},{"key":"10.1124\/pr.118.015578_bib77","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1124\/mol.114.096776","article-title":"Targeted disruption of organic cation transporter 3 attenuates the pharmacologic response to metformin","volume":"88","author":"Chen","year":"2015","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib78","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1515\/hsz-2016-0236","article-title":"Tropane alkaloids as substrates and inhibitors of human organic cation transporters of the SLC22 (OCT) and the SLC47 (MATE) families","volume":"398","author":"Chen","year":"2017","journal-title":"Biol Chem"},{"key":"10.1124\/pr.118.015578_bib79","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/tpj.2011.60","article-title":"Genetic and epigenetic regulation of the organic cation transporter 3, SLC22A3","volume":"13","author":"Chen","year":"2013","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pr.118.015578_bib80","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1097\/FPC.0b013e32833fe789","article-title":"Role of organic cation transporter 3 (SLC22A3) and its missense variants in the pharmacologic action of metformin","volume":"20","author":"Chen","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib81","doi-asserted-by":"crossref","first-page":"9983","DOI":"10.1073\/pnas.1314939111","article-title":"OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin","volume":"111","author":"Chen","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib82","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1124\/jpet.110.170159","article-title":"Genetic polymorphisms in organic cation transporter 1 (OCT1) in Chinese and Japanese populations exhibit altered function","volume":"335","author":"Chen","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib83","article-title":"Sorafenib activity and disposition in liver cancer does not depend on organic cation transporter 1 (OCT1)","author":"Chen","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib84","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/FPC.0b013e32832cc7e9","article-title":"Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin","volume":"19","author":"Chen","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib85","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/tpj.2008.19","article-title":"Genetic variants in multidrug and toxic compound extrusion-1, hMATE1, alter transport function","volume":"9","author":"Chen","year":"2009","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pr.118.015578_bib86","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1124\/jpet.107.123554","article-title":"Transport of paraquat by human organic cation transporters and multidrug and toxic compound extrusion family","volume":"322","author":"Chen","year":"2007","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib87","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1124\/dmd.108.022681","article-title":"Characterization of the disposition and toxicokinetics of N-butylpyridinium chloride in male F-344 rats and female B6C3F1 mice and its transport by organic cation transporter 2","volume":"37","author":"Cheng","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib88","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1111\/bcp.12476","article-title":"Verapamil decreases the glucose-lowering effect of metformin in healthy volunteers","volume":"78","author":"Cho","year":"2014","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib89","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/clpt.2011.165","article-title":"A common 5\u2032-UTR variant in MATE2-K is associated with poor response to metformin","volume":"90","author":"Choi","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib90","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1124\/dmd.31.11.1337","article-title":"Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats","volume":"31","author":"Choudhuri","year":"2003","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib91","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/FPC.0b013e32834c0010","article-title":"The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c","volume":"21","author":"Christensen","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib92","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1097\/FPC.0b013e328364a57d","article-title":"A gene-gene interaction between polymorphisms in the OCT2 and MATE1 genes influences the renal clearance of metformin","volume":"23","author":"Christensen","year":"2013","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib93","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s00228-015-1853-8","article-title":"Steady-state pharmacokinetics of metformin is independent of the OCT1 genotype in healthy volunteers","volume":"71","author":"Christensen","year":"2015","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib94","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/cpt.445","article-title":"Transporters affecting biochemical test results: creatinine-drug interactions","volume":"100","author":"Chu","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib95","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.2353\/ajpath.2010.090610","article-title":"Organic cation transporter 2 mediates cisplatin-induced oto- and nephrotoxicity and is a target for protective interventions","volume":"176","author":"Ciarimboli","year":"2010","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.118.015578_bib96","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1021\/mp100329u","article-title":"New clues for nephrotoxicity induced by ifosfamide: preferential renal uptake via the human organic cation transporter 2","volume":"8","author":"Ciarimboli","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib97","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1681\/ASN.2004040256","article-title":"Individual PKC-phosphorylation sites in organic cation transporter 1 determine substrate selectivity and transport regulation","volume":"16","author":"Ciarimboli","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.118.015578_bib98","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1158\/1078-0432.CCR-11-2503","article-title":"Proximal tubular secretion of creatinine by organic cation transporter OCT2 in cancer patients","volume":"18","author":"Ciarimboli","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pr.118.015578_bib99","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0002-9440(10)61234-5","article-title":"Cisplatin nephrotoxicity is critically mediated via the human organic cation transporter 2","volume":"167","author":"Ciarimboli","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.118.015578_bib100","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1002\/jcp.20081","article-title":"Regulation of the human organic cation transporter hOCT1","volume":"201","author":"Ciarimboli","year":"2004","journal-title":"J Cell Physiol"},{"key":"10.1124\/pr.118.015578_bib101","first-page":"1","article-title":"Human UGT2B7 catalyzes morphine glucuronidation","volume":"25","author":"Coffman","year":"1997","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib102","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1046\/j.1365-2125.1997.00596.x","article-title":"Association between CYP2C19 genotype and proguanil oxidative polymorphism","volume":"43","author":"Coller","year":"1997","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib103","doi-asserted-by":"crossref","first-page":"3758","DOI":"10.1038\/s41598-018-22170-7","article-title":"Characterization of exosomal SLC22A5 (OCTN2) carnitine transporter","volume":"8","author":"Console","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pr.118.015578_bib104","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1464-5491.2007.02078.x","article-title":"Initial monotherapy with either metformin or sulphonylureas often fails to achieve or maintain current glycaemic goals in patients with type 2 diabetes in UK primary care","volume":"24","author":"Cook","year":"2007","journal-title":"Diabet Med"},{"key":"10.1124\/pr.118.015578_bib105","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/mp.2014.86","article-title":"Brain organic cation transporter 2 controls response and vulnerability to stress and GSK3\u03b2 signaling","volume":"20","author":"Courouss\u00e9","year":"2015","journal-title":"Mol Psychiatry"},{"key":"10.1124\/pr.118.015578_bib106","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.pharmthera.2014.09.008","article-title":"Role of organic cation transporters (OCTs) in the brain","volume":"146","author":"Courouss\u00e9","year":"2015","journal-title":"Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib107","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1182\/blood-2005-02-0694","article-title":"hOCT 1 and resistance to imatinib","volume":"106","author":"Crossman","year":"2005","journal-title":"Blood"},{"key":"10.1124\/pr.118.015578_bib108","doi-asserted-by":"crossref","first-page":"8043","DOI":"10.1073\/pnas.0900358106","article-title":"The organic cation transporter-3 is a pivotal modulator of neurodegeneration in the nigrostriatal dopaminergic pathway","volume":"106","author":"Cui","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib109","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1136\/gut.2010.215947","article-title":"Common variant in 6q26-q27 is associated with distal colon cancer in an Asian population","volume":"60","author":"Cui","year":"2011","journal-title":"Gut"},{"key":"10.1124\/pr.118.015578_bib110","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1053\/gast.2002.32415","article-title":"The contribution of NOD2 gene mutations to the risk and site of disease in inflammatory bowel disease","volume":"122","author":"Cuthbert","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.118.015578_bib111","doi-asserted-by":"crossref","first-page":"793","DOI":"10.2174\/138920011798357060","article-title":"Overview of SLC22A and SLCO families of drug uptake transporters in the context of cancer treatments","volume":"12","author":"Cutler","year":"2011","journal-title":"Curr Drug Metab"},{"key":"10.1124\/pr.118.015578_bib112","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.compbiolchem.2017.03.007","article-title":"Structural modeling of human organic cation transporters","volume":"68","author":"Dakal","year":"2017","journal-title":"Comput Biol Chem"},{"key":"10.1124\/pr.118.015578_bib113","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/nature09406","article-title":"Structure of a fucose transporter in an outward-open conformation","volume":"467","author":"Dang","year":"2010","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib114","doi-asserted-by":"crossref","first-page":"F520","DOI":"10.1152\/ajprenal.00075.2011","article-title":"Interaction of H+ with the extracellular and intracellular aspects of hMATE1","volume":"301","author":"Dangprapai","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib115","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1007\/s004240050721","article-title":"Basolateral choline transport in isolated rabbit renal proximal tubules","volume":"436","author":"Dantzler","year":"1998","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.118.015578_bib116","doi-asserted-by":"crossref","first-page":"27078","DOI":"10.1074\/jbc.M110.109678","article-title":"Colon OCTN2 gene expression is up-regulated by peroxisome proliferator-activated receptor gamma in humans and mice and contributes to local and systemic carnitine homeostasis","volume":"285","author":"D\u2019Argenio","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib117","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/BF00373884","article-title":"Luminal transport system for H+\/organic cations in the rat proximal tubule: kinetics, dependence on pH; specificity as compared with the contraluminal organic cation-transport system","volume":"430","author":"David","year":"1995","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.118.015578_bib118","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/sj.bjp.0705538","article-title":"Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice","volume":"140","author":"David","year":"2003","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib119","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jneumeth.2004.09.011","article-title":"Transport mechanisms governing serotonin clearance in vivo revealed by high-speed chronoamperometry","volume":"143","author":"Daws","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1124\/pr.118.015578_bib120","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/S0006-291X(88)80729-0","article-title":"Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl\/bufI)","volume":"152","author":"Dayer","year":"1988","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001169","article-title":"The activities of current antimalarial drugs on the life cycle stages of Plasmodium: a comparative study with human and rodent parasites","volume":"9","author":"Delves","year":"2012","journal-title":"PLoS Med"},{"key":"10.1124\/pr.118.015578_bib122","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature14655","article-title":"Molecular basis of ligand recognition and transport by glucose transporters","volume":"526","author":"Deng","year":"2015","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib123","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/10408440701669959","article-title":"Paraquat poisonings: mechanisms of lung toxicity, clinical features, and treatment","volume":"38","author":"Dinis-Oliveira","year":"2008","journal-title":"Crit Rev Toxicol"},{"key":"10.1124\/pr.118.015578_bib124","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/0006-2952(94)90397-2","article-title":"Characterization of the enzyme responsible for the metabolism of sumatriptan in human liver","volume":"47","author":"Dixon","year":"1994","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib125","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.ejps.2018.07.040","article-title":"Expression analysis of human solute carrier (SLC) family transporters in nasal mucosa and RPMI 2650 cells","volume":"123","author":"Dolberg","year":"2018","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib126","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s00204-012-0821-7","article-title":"Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update","volume":"86","author":"dos Santos","year":"2012","journal-title":"Arch Toxicol"},{"key":"10.1124\/pr.118.015578_bib127","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1208\/s12248-014-9649-9","article-title":"The poorly membrane permeable antipsychotic drugs amisulpride and sulpiride are substrates of the organic cation transporters from the SLC22 family","volume":"16","author":"Dos Santos Pereira","year":"2014","journal-title":"AAPS J"},{"key":"10.1124\/pr.118.015578_bib128","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1158\/0008-5472.CAN-16-2548","article-title":"OCTN1 is a high-affinity carrier of nucleoside analogues","volume":"77","author":"Drenberg","year":"2017","journal-title":"Cancer Res"},{"key":"10.1124\/pr.118.015578_bib129","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1016\/S0022-3565(24)35400-X","article-title":"Kinetic and selectivity differences between rodent, rabbit, and human organic cation transporters (OCT1)","volume":"292","author":"Dresser","year":"2000","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib130","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1023\/A:1019870831174","article-title":"Interactions of n-tetraalkylammonium compounds and biguanides with a human renal organic cation transporter (hOCT2)","volume":"19","author":"Dresser","year":"2002","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib131","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1002\/cpt.1301","article-title":"Protein abundance of clinically relevant drug transporters in the human liver and intestine: a comparative analysis in paired tissue specimens","volume":"105","author":"Drozdzik","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib132","doi-asserted-by":"crossref","first-page":"3547","DOI":"10.1021\/mp500330y","article-title":"Protein abundance of clinically relevant multidrug transporters along the entire length of the human intestine","volume":"11","author":"Drozdzik","year":"2014","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib133","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1124\/jpet.110.170142","article-title":"Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3","volume":"335","author":"Duan","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib134","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/sj.bjp.0703518","article-title":"The organic cation transporter OCT2 mediates the uptake of beta-adrenoceptor antagonists across the apical membrane of renal LLC-PK(1) cell monolayers","volume":"131","author":"Dudley","year":"2000","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib135","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.2337\/db14-1388","article-title":"Association of organic cation transporter 1 with intolerance to metformin in type 2 diabetes: a GoDARTS study","volume":"64","author":"Dujic","year":"2015","journal-title":"Diabetes"},{"key":"10.1124\/pr.118.015578_bib136","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/cpt.567","article-title":"Variants in pharmacokinetic transporters and glycemic response to metformin: a metgen meta-analysis","volume":"101","author":"Dujic","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib137","doi-asserted-by":"crossref","first-page":"31925","DOI":"10.1074\/jbc.274.45.31925","article-title":"Cloning of the human thiamine transporter, a member of the folate transporter family","volume":"274","author":"Dutta","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib138","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"10.1124\/pr.118.015578_bib139","doi-asserted-by":"crossref","first-page":"F1799","DOI":"10.1152\/ajprenal.00356.2007","article-title":"Creatine synthesis: production of guanidinoacetate by the rat and human kidney in vivo","volume":"293","author":"Edison","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib140","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1526-4637.2005.05007.x","article-title":"Ethnic similarities and differences in the chronic pain experience: a comparison of African American, Hispanic, and White patients","volume":"6","author":"Edwards","year":"2005","journal-title":"Pain Med"},{"key":"10.1124\/pr.118.015578_bib141","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/ng.90","article-title":"Multiple newly identified loci associated with prostate cancer susceptibility","volume":"40","author":"Eeles","year":"2008","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib142","doi-asserted-by":"crossref","first-page":"31561","DOI":"10.1074\/jbc.M112.388793","article-title":"A substrate binding hinge domain is critical for transport-related structural changes of organic cation transporter 1","volume":"287","author":"Egenberger","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib143","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJM200202213460812","article-title":"Genes, microbes, and T cells--new therapeutic targets in Crohn\u2019s disease","volume":"346","author":"Elson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.118.015578_bib144","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejps.2005.11.002","article-title":"The role of transporters in drug interactions","volume":"27","author":"Endres","year":"2006","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib145","doi-asserted-by":"crossref","first-page":"50042","DOI":"10.1074\/jbc.M407913200","article-title":"Identification and characterization of a novel monoamine transporter in the human brain","volume":"279","author":"Engel","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib146","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0006-291X(02)02853-X","article-title":"Organic anion and cation transporters occur in pairs of similar and similarly expressed genes","volume":"300","author":"Eraly","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib147","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1006\/mgme.2000.3112","article-title":"Identification and characterization of the human and mouse SLC19A3 gene: a novel member of the reduced folate family of micronutrient transporter genes","volume":"71","author":"Eudy","year":"2000","journal-title":"Mol Genet Metab"},{"key":"10.1124\/pr.118.015578_bib148","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.clpt.6100405","article-title":"Effect of human renal cationic transporter inhibition on the pharmacokinetics of varenicline, a new therapy for smoking cessation: an in vitro-in vivo study","volume":"83","author":"Feng","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib149","doi-asserted-by":"crossref","DOI":"10.1002\/humu.23839","article-title":"A mutation creating an upstream translation initiation codon in SLC22A5 5'UTR is a frequent cause of primary carnitine deficiency","author":"Ferdinandusse","year":"2019","journal-title":"Hum Mutat"},{"key":"10.1124\/pr.118.015578_bib150","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1006\/frne.1996.0012","article-title":"Electrophysiology of the circumventricular organs","volume":"17","author":"Ferguson","year":"1996","journal-title":"Front Neuroendocrinol"},{"key":"10.1124\/pr.118.015578_bib151","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s11064-017-2288-7","article-title":"L-Carnitine and acetyl-L-carnitine roles and neuroprotection in developing brain","volume":"42","author":"Ferreira","year":"2017","journal-title":"Neurochem Res"},{"key":"10.1124\/pr.118.015578_bib152","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1158\/1078-0432.CCR-07-4793","article-title":"Interaction of Cisplatin with the human organic cation transporter 2","volume":"14","author":"Filipski","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pr.118.015578_bib153","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/clpt.2009.139","article-title":"Contribution of organic cation transporter 2 (OCT2) to cisplatin-induced nephrotoxicity","volume":"86","author":"Filipski","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib154","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1158\/1078-0432.CCR-18-2380","article-title":"L-carnitine-mediated tumor cell protection and poor patient survival associated with OCTN2 overexpression in glioblastoma multiforme","volume":"25","author":"Fink","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pr.118.015578_bib155","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0016-5085(98)70381-6","article-title":"Inflammatory bowel disease: etiology and pathogenesis","volume":"115","author":"Fiocchi","year":"1998","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.118.015578_bib156","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/humu.23315","article-title":"Functional and molecular studies in primary carnitine deficiency","volume":"38","author":"Frigeni","year":"2017","journal-title":"Hum Mutat"},{"key":"10.1124\/pr.118.015578_bib157","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2217\/pgs.13.94","article-title":"OCT1 genetic variants influence the pharmacokinetics of morphine in children","volume":"14","author":"Fukuda","year":"2013","journal-title":"Pharmacogenomics"},{"key":"10.1124\/pr.118.015578_bib158","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1111\/jphp.12574","article-title":"L503F variant of carnitine\/organic cation transporter 1 efficiently transports metformin and other biguanides","volume":"68","author":"Futatsugi","year":"2016","journal-title":"J Pharm Pharmacol"},{"key":"10.1124\/pr.118.015578_bib159","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1128\/AAC.00907-16","article-title":"Organic cation transporter 2 overexpression may confer an increased risk of gentamicin-induced nephrotoxicity","volume":"60","author":"Gai","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.118.015578_bib160","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bcp.2010.03.033","article-title":"Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines","volume":"80","author":"Galetti","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib161","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1007\/s00429-016-1315-9","article-title":"Organic cation transporter 3 (OCT3) is localized to intracellular and surface membranes in select glial and neuronal cells within the basolateral amygdaloid complex of both rats and mice","volume":"222","author":"Gasser","year":"2017","journal-title":"Brain Struct Funct"},{"key":"10.1124\/pr.118.015578_bib162","doi-asserted-by":"crossref","first-page":"8758","DOI":"10.1523\/JNEUROSCI.0570-06.2006","article-title":"Corticosterone-sensitive monoamine transport in the rat dorsomedial hypothalamus: potential role for organic cation transporter 3 in stress-induced modulation of monoaminergic neurotransmission","volume":"26","author":"Gasser","year":"2006","journal-title":"J Neurosci"},{"key":"10.1124\/pr.118.015578_bib163","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cne.21921","article-title":"Distribution of organic cation transporter 3, a corticosterone-sensitive monoamine transporter, in the rat brain","volume":"512","author":"Gasser","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1124\/pr.118.015578_bib164","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.bbamcr.2006.04.014","article-title":"Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration","volume":"1773","author":"Geier","year":"2007","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib165","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/clpt.2013.175","article-title":"Profiling solute carrier transporters in the human blood-brain barrier","volume":"94","author":"Geier","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib166","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrd3028","article-title":"Membrane transporters in drug development","volume":"9","author":"Giacomini","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.118.015578_bib167","doi-asserted-by":"crossref","first-page":"9206","DOI":"10.1074\/jbc.M008745200","article-title":"Interaction of the type IIa Na\/Pi cotransporter with PDZ proteins","volume":"276","author":"Gisler","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib168","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1586\/14737159.2015.1039515","article-title":"Choline metabolism-based molecular diagnosis of cancer: an update","volume":"15","author":"Glunde","year":"2015","journal-title":"Expert Rev Mol Diagn"},{"key":"10.1124\/pr.118.015578_bib169","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1186\/ar93","article-title":"Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset","volume":"2","author":"Goldbach-Mansky","year":"2000","journal-title":"Arthritis Res"},{"key":"10.1124\/pr.118.015578_bib170","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMra020777","article-title":"Chronic myeloid leukemia--advances in biology and new approaches to treatment","volume":"349","author":"Goldman","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.118.015578_bib171","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1124\/mol.117.110767","article-title":"Assay conditions influence affinities of rat organic cation transporter 1: analysis of mutagenesis in the modeled outward-facing cleft by measuring effects of substrates and inhibitors on initial uptake","volume":"93","author":"Gorboulev","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib172","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1124\/mol.104.008821","article-title":"Subtype-specific affinity for corticosterone of rat organic cation transporters rOCT1 and rOCT2 depends on three amino acids within the substrate binding region","volume":"67","author":"Gorboulev","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib173","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1089\/dna.1997.16.871","article-title":"Cloning and characterization of two human polyspecific organic cation transporters","volume":"16","author":"Gorboulev","year":"1997","journal-title":"DNA Cell Biol"},{"key":"10.1124\/pr.118.015578_bib174","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0026-895X(24)12391-7","article-title":"Selectivity of the polyspecific cation transporter rOCT1 is changed by mutation of aspartate 475 to glutamate","volume":"56","author":"Gorboulev","year":"1999","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib175","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1124\/mol.107.040170","article-title":"High-affinity cation binding to organic cation transporter 1 induces movement of helix 11 and blocks transport after mutations in a modeled interaction domain between two helices","volume":"73","author":"Gorbunov","year":"2008","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib176","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1007\/s00018-011-0694-6","article-title":"LAPTM4A interacts with hOCT2 and regulates its endocytotic recruitment","volume":"68","author":"Grabner","year":"2011","journal-title":"Cell Mol Life Sci"},{"key":"10.1124\/pr.118.015578_bib177","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib178","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1002\/hep.510290530","article-title":"Cloning and functional expression of a mouse liver organic cation transporter","volume":"29","author":"Green","year":"1999","journal-title":"Hepatology"},{"key":"10.1124\/pr.118.015578_bib179","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1124\/dmd.108.023929","article-title":"The carnitine transporter SLC22A5 is not a general drug transporter, but it efficiently translocates mildronate","volume":"37","author":"Grigat","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib180","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.bcp.2007.04.015","article-title":"Probing the substrate specificity of the ergothioneine transporter with methimazole, hercynine, and organic cations","volume":"74","author":"Grigat","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib181","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1111\/j.1471-4159.1990.tb03121.x","article-title":"Tissue distribution of human monoamine oxidase A and B mRNA","volume":"55","author":"Grimsby","year":"1990","journal-title":"J Neurochem"},{"key":"10.1124\/pr.118.015578_bib182","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jpba.2013.07.031","article-title":"LC-MS\/MS-based quantification of clinically relevant intestinal uptake and efflux transporter proteins","volume":"85","author":"Gr\u00f6er","year":"2013","journal-title":"J Pharm Biomed Anal"},{"key":"10.1124\/pr.118.015578_bib183","doi-asserted-by":"crossref","first-page":"741","DOI":"10.3892\/or.2012.2153","article-title":"Instability of mRNA expression signatures of drug transporters in chronic myeloid leukemia patients resistant to imatinib","volume":"29","author":"Gromicho","year":"2013","journal-title":"Oncol Rep"},{"key":"10.1124\/pr.118.015578_bib184","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1016\/j.ajpath.2011.02.020","article-title":"Selective regulation of cardiac organic cation transporter novel type 2 (OCTN2) in dilated cardiomyopathy","volume":"178","author":"Grube","year":"2011","journal-title":"Am J Pathol"},{"key":"10.1124\/pr.118.015578_bib185","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1161\/CIRCULATIONAHA.105.586107","article-title":"Uptake of cardiovascular drugs into the human heart: expression, regulation, and function of the carnitine transporter OCTN2 (SLC22A5)","volume":"113","author":"Grube","year":"2006","journal-title":"Circulation"},{"key":"10.1124\/pr.118.015578_bib186","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/372549a0","article-title":"Drug excretion mediated by a new prototype of polyspecific transporter","volume":"372","author":"Gr\u00fcndemann","year":"1994","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib187","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1124\/jpet.102.044404","article-title":"Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2)","volume":"304","author":"Gr\u00fcndemann","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib188","doi-asserted-by":"crossref","first-page":"5256","DOI":"10.1073\/pnas.0408624102","article-title":"Discovery of the ergothioneine transporter","volume":"102","author":"Gr\u00fcndemann","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib189","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/1557","article-title":"Molecular identification of the corticosterone-sensitive extraneuronal catecholamine transporter","volume":"1","author":"Gr\u00fcndemann","year":"1998","journal-title":"Nat Neurosci"},{"key":"10.1124\/pr.118.015578_bib190","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1124\/jpet.111.190561","article-title":"Human organic cation transporter 1 is expressed in lymphoma cells and increases susceptibility to irinotecan and paclitaxel","volume":"341","author":"Gupta","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib191","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1471-4159.2004.02180.x","article-title":"The localisation of the extraneuronal monoamine transporter (EMT) in rat brain","volume":"88","author":"Haag","year":"2004","journal-title":"J Neurochem"},{"key":"10.1124\/pr.118.015578_bib192","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/FPC.0b013e328330eeca","article-title":"Identification and characterization of novel polymorphisms in the basal promoter of the human transporter, MATE1","volume":"19","author":"Ha Choi","year":"2009","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib193","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0136451","article-title":"Substrate-dependent inhibition of the human organic cation transporter OCT2: a comparison of metformin with experimental substrates","volume":"10","author":"Hacker","year":"2015","journal-title":"PLoS One"},{"key":"10.1124\/pr.118.015578_bib194","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/mol.112.084517","article-title":"Organic cation transporter 1 (OCT1\/mOct1) is localized in the apical membrane of Caco-2 cell monolayers and enterocytes","volume":"84","author":"Han","year":"2013","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib195","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1124\/jpet.114.220350","article-title":"Four cation-selective transporters contribute to apical uptake and accumulation of metformin in Caco-2 cell monolayers","volume":"352","author":"Han","year":"2015","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib196","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1038\/nm.3361","article-title":"Brown and beige fat: development, function and therapeutic potential","volume":"19","author":"Harms","year":"2013","journal-title":"Nat Med"},{"key":"10.1124\/pr.118.015578_bib197","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/s41598-017-01438-4","article-title":"Importance of the novel organic cation transporter 1 for tyrosine kinase inhibition by saracatinib in rheumatoid arthritis synovial fibroblasts","volume":"7","author":"Harrach","year":"2017","journal-title":"Sci Rep"},{"key":"10.1124\/pr.118.015578_bib198","doi-asserted-by":"crossref","first-page":"e470","DOI":"10.1038\/bcj.2016.79","article-title":"MATE1 regulates cellular uptake and sensitivity to imatinib in CML patients","volume":"6","author":"Harrach","year":"2016","journal-title":"Blood Cancer J"},{"key":"10.1124\/pr.118.015578_bib199","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.ejphar.2004.07.098","article-title":"Human organic cation transporter 3 mediates the transport of antiarrhythmic drugs","volume":"499","author":"Hasannejad","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib200","doi-asserted-by":"crossref","first-page":"344","DOI":"10.2165\/00003088-199324040-00007","article-title":"Morphine pharmacokinetics and metabolism in humans: enterohepatic cycling and relative contribution of metabolites to active opioid concentrations","volume":"24","author":"Hasselstr\u00f6m","year":"1993","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib201","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.1469-1809.2000.6430267.x","article-title":"Molecular cloning, functional characterization and genomic organization of four alternatively spliced isoforms of the human organic cation transporter 1 (hOCT1\/SLC22A1)","volume":"63","author":"Hayer","year":"1999","journal-title":"Ann Hum Genet"},{"key":"10.1124\/pr.118.015578_bib202","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.bjp.0704785","article-title":"Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3","volume":"136","author":"Hayer-Zillgen","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib203","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nature09408","article-title":"Structure of a cation-bound multidrug and toxic compound extrusion transporter","volume":"467","author":"He","year":"2010","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib204","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-017-4372-6","article-title":"Repurposing metformin for the prevention of cancer and cancer recurrence","volume":"60","author":"Heckman-Stoddard","year":"2017","journal-title":"Diabetologia"},{"key":"10.1124\/pr.118.015578_bib205","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/1471-2407-12-109","article-title":"Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance","volume":"12","author":"Heise","year":"2012","journal-title":"BMC Cancer"},{"key":"10.1124\/pr.118.015578_bib206","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/ng1268","article-title":"A putative RUNX1 binding site variant between SLC9A3R1 and NAT9 is associated with susceptibility to psoriasis","volume":"35","author":"Helms","year":"2003","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib207","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1021\/jm400966v","article-title":"Identification of novel substrates and structure-activity relationship of cellular uptake mediated by human organic cation transporters 1 and 2","volume":"56","author":"Hendrickx","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pr.118.015578_bib208","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.yfrne.2003.07.001","article-title":"Central mechanisms of stress integration: hierarchical circuitry controlling hypothalamo-pituitary-adrenocortical responsiveness","volume":"24","author":"Herman","year":"2003","journal-title":"Front Neuroendocrinol"},{"key":"10.1124\/pr.118.015578_bib209","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/hep.26425","article-title":"Expression of SLC22A1 variants may affect the response of hepatocellular carcinoma and cholangiocarcinoma to sorafenib","volume":"58","author":"Herraez","year":"2013","journal-title":"Hepatology"},{"key":"10.1124\/pr.118.015578_bib210","doi-asserted-by":"crossref","first-page":"C678","DOI":"10.1152\/ajpcell.00090.2006","article-title":"Wide variety of locations for rodent MATE1, a transporter protein that mediates the final excretion step for toxic organic cations","volume":"291","author":"Hiasa","year":"2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1124\/pr.118.015578_bib211","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1124\/dmd.112.044875","article-title":"Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics","volume":"40","author":"Higgins","year":"2012","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib212","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1124\/dmd.107.014902","article-title":"Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines","volume":"35","author":"Hilgendorf","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib213","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","article-title":"Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies","volume":"102","author":"Ho","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1124\/pr.118.015578_bib214","first-page":"342","article-title":"Pharmacokinetic\/Pharmacodynamic characteristics of the beta-2-agonists terbutaline, salbutamol and fenoterol","volume":"30","author":"Hochhaus","year":"1992","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1124\/pr.118.015578_bib215","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0022-3565(25)32276-7","article-title":"Mechanisms of organic cation transport in kidney plasma membrane vesicles: 1. Countertransport studies","volume":"215","author":"Holohan","year":"1980","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib216","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.str.2007.06.004","article-title":"Conformational change in an MFS protein: MD simulations of LacY","volume":"15","author":"Holyoake","year":"2007","journal-title":"Structure"},{"key":"10.1124\/pr.118.015578_bib217","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1165\/rcmb.2006-0230OC","article-title":"Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway","volume":"36","author":"Horvath","year":"2007","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/pr.118.015578_bib218","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1046\/j.1365-2125.1998.00807.x","article-title":"Relationship between proguanil metabolic ratio and CYP2C19 genotype in a Caucasian population","volume":"46","author":"Hoskins","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib219","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1158\/1535-7163.MCT-11-0980","article-title":"Inhibition of OCTN2-mediated transport of carnitine by etoposide","volume":"11","author":"Hu","year":"2012","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/pr.118.015578_bib220","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1158\/1078-0432.CCR-07-4913","article-title":"Interaction of imatinib with human organic ion carriers","volume":"14","author":"Hu","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pr.118.015578_bib221","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.oooo.2018.01.009","article-title":"Differential expression of organic cation transporter 3 in oral submucous fibrosis-associated buccal squamous cell carcinoma","volume":"126","author":"Hu","year":"2018","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"10.1124\/pr.118.015578_bib222","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1126\/science.1087619","article-title":"Structure and mechanism of the glycerol-3-phosphate transporter from Escherichia coli","volume":"301","author":"Huang","year":"2003","journal-title":"Science"},{"key":"10.1124\/pr.118.015578_bib223","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1124\/dmd.116.069807","article-title":"Expression of organic anion transporting polypeptide 1A2 in red blood cells and its potential impact on antimalarial therapy","volume":"44","author":"Hubeny","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib224","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s11095-012-0890-6","article-title":"Effect of the fluoroquinolone antibacterial agent DX-619 on the apparent formation and renal clearances of 6\u03b2-hydroxycortisol, an endogenous probe for CYP3A4 inhibition, in healthy subjects","volume":"30","author":"Imamura","year":"2013","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib225","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/clpt.2010.232","article-title":"Prediction of fluoroquinolone-induced elevation in serum creatinine levels: a case of drug-endogenous substance interaction involving the inhibition of renal secretion","volume":"89","author":"Imamura","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib226","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1046\/j.1471-4159.2003.01566.x","article-title":"Expression and functional characterization of the extraneuronal monoamine transporter in normal human astrocytes","volume":"84","author":"Inazu","year":"2003","journal-title":"J Neurochem"},{"key":"10.1124\/pr.118.015578_bib227","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002078","article-title":"Identification, replication, and functional fine-mapping of expression quantitative trait loci in primary human liver tissue","volume":"7","author":"Innocenti","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1124\/pr.118.015578_bib228","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1093\/annonc\/mdu155","article-title":"Hepatic arterial infusion chemotherapy with cisplatin before radical local treatment of early hepatocellular carcinoma (JIS score 0\/1) improves survival","volume":"25","author":"Ishikawa","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1124\/pr.118.015578_bib229","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/clpt.2012.138","article-title":"N-methylnicotinamide is an endogenous probe for evaluation of drug-drug interactions involving multidrug and toxin extrusions (MATE1 and MATE2-K)","volume":"92","author":"Ito","year":"2012","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib230","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1124\/jpet.111.184986","article-title":"Competitive inhibition of the luminal efflux by multidrug and toxin extrusions, but not basolateral uptake by organic cation transporter 2, is the likely mechanism underlying the pharmacokinetic drug-drug interactions caused by cimetidine in the kidney","volume":"340","author":"Ito","year":"2012","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib231","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2133\/dmpk.19.308","article-title":"Seven novel single nucleotide polymorphisms in the human SLC22A1 gene encoding organic cation transporter 1 (OCT1)","volume":"19","author":"Itoda","year":"2004","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib232","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10157-012-0638-y","article-title":"Effects of genetic variants in SLC22A2 organic cation transporter 2 and SLC47A1 multidrug and toxin extrusion 1 transporter on cisplatin-induced adverse events","volume":"16","author":"Iwata","year":"2012","journal-title":"Clin Exp Nephrol"},{"key":"10.1124\/pr.118.015578_bib233","doi-asserted-by":"crossref","first-page":"6496","DOI":"10.1128\/MCB.25.15.6496-6508.2005","article-title":"IRIP, a new ischemia\/reperfusion-inducible protein that participates in the regulation of transporter activity","volume":"25","author":"Jiang","year":"2005","journal-title":"Mol Cell Biol"},{"key":"10.1124\/pr.118.015578_bib234","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1124\/dmd.114.059097","article-title":"Selective inhibition of human solute carrier transporters by multikinase inhibitors","volume":"42","author":"Johnston","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib235","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1124\/jpet.111.181297","article-title":"Oxaliplatin transport mediated by organic cation\/carnitine transporters OCTN1 and OCTN2 in overexpressing human embryonic kidney 293 cells and rat dorsal root ganglion neurons","volume":"338","author":"Jong","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib236","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1472-8206.2012.01071.x","article-title":"The mitochondrial fluorescent dye rhodamine 123 is a high-affinity substrate for organic cation transporters (OCTs) 1 and 2","volume":"28","author":"Jouan","year":"2014","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib237","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1124\/dmd.108.020826","article-title":"Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection","volume":"36","author":"Jung","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib238","first-page":"51","article-title":"Methods of GFR determination--creatinine clearance after cimetidine administration in clinical practice","volume":"31","author":"Kabat-Koperska","year":"2004","journal-title":"Acta Med Austriaca"},{"key":"10.1124\/pr.118.015578_bib239","doi-asserted-by":"crossref","first-page":"2805","DOI":"10.1200\/JCO.2002.09.064","article-title":"Patient-tailored antiemetic treatment with 5-hydroxytryptamine type 3 receptor antagonists according to cytochrome P-450 2D6 genotypes","volume":"20","author":"Kaiser","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1124\/pr.118.015578_bib240","doi-asserted-by":"crossref","first-page":"G1211","DOI":"10.1152\/ajpgi.90360.2008","article-title":"Regulation of basal core promoter activity of human organic cation transporter 1 (OCT1\/SLC22A1)","volume":"295","author":"Kajiwara","year":"2008","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/pr.118.015578_bib241","doi-asserted-by":"crossref","first-page":"F1564","DOI":"10.1152\/ajprenal.00322.2007","article-title":"Critical roles of Sp1 in gene expression of human and rat H+\/organic cation antiporter MATE1","volume":"293","author":"Kajiwara","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib242","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/jhg.2008.1","article-title":"Identification of multidrug and toxin extrusion (MATE1 and MATE2-K) variants with complete loss of transport activity","volume":"54","author":"Kajiwara","year":"2009","journal-title":"J Hum Genet"},{"key":"10.1124\/pr.118.015578_bib243","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0006-291X(02)00926-9","article-title":"Functional characterization of mouse cation transporter mOCT2 compared with mOCT1","volume":"296","author":"Kakehi","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib244","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2133\/dmpk.22.287","article-title":"Role of human hepatocyte nuclear factor 4alpha in the expression of drug-metabolizing enzymes and transporters in human hepatocytes assessed by use of small interfering RNA","volume":"22","author":"Kamiyama","year":"2007","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib245","first-page":"317","article-title":"Proguanil disposition and toxicity in malaria patients from Vanuatu with high frequencies of CYP2C19 mutations","volume":"9","author":"Kaneko","year":"1999","journal-title":"Pharmacogenetics"},{"key":"10.1124\/pr.118.015578_bib246","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1124\/dmd.106.013581","article-title":"Identification and functional characterization of genetic variants of human organic cation transporters in a Korean population","volume":"35","author":"Kang","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib247","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1182\/blood-2004-02-0711","article-title":"Long-term survival benefit and improved complete cytogenetic and molecular response rates with imatinib mesylate in Philadelphia chromosome-positive chronic-phase chronic myeloid leukemia after failure of interferon-alpha","volume":"104","author":"Kantarjian","year":"2004","journal-title":"Blood"},{"key":"10.1124\/pr.118.015578_bib248","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1182\/blood-2002-05-1451","article-title":"Dose escalation of imatinib mesylate can overcome resistance to standard-dose therapy in patients with chronic myelogenous leukemia","volume":"101","author":"Kantarjian","year":"2003","journal-title":"Blood"},{"key":"10.1124\/pr.118.015578_bib249","doi-asserted-by":"crossref","first-page":"F679","DOI":"10.1152\/ajprenal.2000.279.4.F679","article-title":"Localization of organic cation transporters OCT1 and OCT2 in rat kidney","volume":"279","author":"Karbach","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.25.1.16","article-title":"The syndrome of systemic carnitine deficiency: clinical, morphologic, biochemical, and pathophysiologic features","volume":"25","author":"Karpati","year":"1975","journal-title":"Neurology"},{"key":"10.1124\/pr.118.015578_bib251","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0151543","article-title":"The role of metformin response in lipid metabolism in patients with recent-onset type 2 diabetes: HbA1c level as a criterion for designating patients as responders or nonresponders to metformin","volume":"11","author":"Kashi","year":"2016","journal-title":"PLoS One"},{"key":"10.1124\/pr.118.015578_bib252","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11095-013-1144-y","article-title":"Investigation of endogenous compounds for assessing the drug interactions in the urinary excretion involving multidrug and toxin extrusion proteins","volume":"31","author":"Kato","year":"2014","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib253","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1007\/s11095-010-0076-z","article-title":"Gene knockout and metabolome analysis of carnitine\/organic cation transporter OCTN1","volume":"27","author":"Kato","year":"2010","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib254","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1124\/mol.104.002212","article-title":"PDZK1 directly regulates the function of organic cation\/carnitine transporter OCTN2","volume":"67","author":"Kato","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib255","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1124\/mol.106.024158","article-title":"Organic cation\/carnitine transporter OCTN2 (Slc22a5) is responsible for carnitine transport across apical membranes of small intestinal epithelial cells in mouse","volume":"70","author":"Kato","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib256","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/jps.20190","article-title":"Functional characterization of human organic cation transporter OCTN1 single nucleotide polymorphisms in the Japanese population","volume":"93","author":"Kawasaki","year":"2004","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib257","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1021\/acs.molpharmaceut.7b00627","article-title":"Affinity of ketamine to clinically relevant transporters","volume":"15","author":"Keiser","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib258","doi-asserted-by":"crossref","first-page":"15971","DOI":"10.1074\/jbc.273.26.15971","article-title":"Cloning and functional characterization of a potential-sensitive, polyspecific organic cation transporter (OCT3) most abundantly expressed in placenta","volume":"273","author":"Kekuda","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib259","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"10.1124\/pr.118.015578_bib260","doi-asserted-by":"crossref","first-page":"37874","DOI":"10.1074\/jbc.M111.289330","article-title":"The large extracellular loop of organic cation transporter 1 influences substrate affinity and is pivotal for oligomerization","volume":"286","author":"Keller","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib261","doi-asserted-by":"crossref","first-page":"12253","DOI":"10.1021\/bi050676c","article-title":"Purification and functional reconstitution of the rat organic cation transporter OCT1","volume":"44","author":"Keller","year":"2005","journal-title":"Biochemistry"},{"key":"10.1124\/pr.118.015578_bib262","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1124\/mol.118.113498","article-title":"Rat organic cation transporter 1 contains three binding sites for substrate 1-methyl-4-phenylpyridinium per monomer","volume":"95","author":"Keller","year":"2019","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib263","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/00008571-200211000-00002","article-title":"Identification of genetic variations of the human organic cation transporter hOCT1 and their functional consequences","volume":"12","author":"Kerb","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1124\/pr.118.015578_bib264","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/jm2001629","article-title":"Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2","volume":"54","author":"Kido","year":"2011","journal-title":"J Med Chem"},{"key":"10.1124\/pr.118.015578_bib265","doi-asserted-by":"crossref","first-page":"3118","DOI":"10.1016\/j.xphs.2019.04.023","article-title":"No inhibition of MATE1\/2K-mediated renal creatinine secretion predicted with ritonavir or cobicistat","volume":"108","author":"Kikuchi","year":"2019","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib266","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.ajhg.2017.08.008","article-title":"Fine mapping and functional analysis reveal a role of SLC22A1 in acylcarnitine transport","volume":"101","author":"Kim","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1124\/pr.118.015578_bib267","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.kint.2016.01.014","article-title":"Advanced chronic kidney disease populations have elevated trimethylamine N-oxide levels associated with increased cardiovascular events","volume":"89","author":"Kim","year":"2016","journal-title":"Kidney Int"},{"key":"10.1124\/pr.118.015578_bib268","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbrc.2013.03.072","article-title":"Identification and functional characterization of novel MATE1 genetic variations in Koreans","volume":"434","author":"Kim","year":"2013","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib269","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.bcp.2009.01.010","article-title":"Transport of guanidine compounds by human organic cation transporters, hOCT1 and hOCT2","volume":"77","author":"Kimura","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib270","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2133\/dmpk.20.379","article-title":"Metformin is a superior substrate for renal organic cation transporter OCT2 rather than hepatic OCT1","volume":"20","author":"Kimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib271","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7326\/0003-4819-137-1-200207020-00009","article-title":"Metformin: an update","volume":"137","author":"Kirpichnikov","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1124\/pr.118.015578_bib272","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.neulet.2005.03.014","article-title":"Behavioral changes following antisense oligonucleotide-induced reduction of organic cation transporter-3 in mice","volume":"382","author":"Kitaichi","year":"2005","journal-title":"Neurosci Lett"},{"key":"10.1124\/pr.118.015578_bib273","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.dmpk.2018.08.005","article-title":"Investigation of non-linear Mate1-mediated efflux of trimethoprim in the mouse kidney as the mechanism underlying drug-drug interactions between trimethoprim and organic cations in the kidney","volume":"34","author":"Kito","year":"2019","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib274","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejps.2015.09.004","article-title":"Renal tubular secretion of pramipexole","volume":"79","author":"Knop","year":"2015","journal-title":"Eur J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib275","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1016\/j.exphem.2004.08.009","article-title":"Expression of organic cation transporter OCTN1 in hematopoietic cells during erythroid differentiation","volume":"32","author":"Kobayashi","year":"2004","journal-title":"Exp Hematol"},{"key":"10.1124\/pr.118.015578_bib276","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1159\/000134720","article-title":"The two human organic cation transporter genes SLC22A1 and SLC22A2 are located on chromosome 6q26","volume":"79","author":"Koehler","year":"1997","journal-title":"Cytogenet Cell Genet"},{"key":"10.1124\/pr.118.015578_bib277","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1146\/annurev.physiol.60.1.243","article-title":"Organic cation transporters in intestine, kidney, liver, and brain","volume":"60","author":"Koepsell","year":"1998","journal-title":"Annu Rev Physiol"},{"key":"10.1124\/pr.118.015578_bib278","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1515\/hsz-2018-0191","article-title":"Multiple binding sites in organic cation transporters require sophisticated procedures to identify interactions of novel drugs","volume":"400","author":"Koepsell","year":"2019","journal-title":"Biol Chem"},{"key":"10.1124\/pr.118.015578_bib279","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s002329900475","article-title":"Molecular pharmacology of organic cation transporters in kidney","volume":"167","author":"Koepsell","year":"1999","journal-title":"J Membr Biol"},{"key":"10.1124\/pr.118.015578_bib280","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1093\/hmg\/8.12.2247","article-title":"Genetic epidemiology of the carnitine transporter OCTN2 gene in a Japanese population and phenotypic characterization in Japanese pedigrees with primary systemic carnitine deficiency","volume":"8","author":"Koizumi","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.118.015578_bib281","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.biocel.2011.03.005","article-title":"Characterization of the human MATE2 proton-coupled polyspecific organic cation exporter","volume":"43","author":"Komatsu","year":"2011","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1124\/pr.118.015578_bib282","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10930-010-9268-y","article-title":"Isoforms, expression, glycosylation, and tissue distribution of CTL2\/SLC44A2","volume":"29","author":"Kommareddi","year":"2010","journal-title":"Protein J"},{"key":"10.1124\/pr.118.015578_bib283","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.568","article-title":"New loci associated with kidney function and chronic kidney disease","volume":"42","author":"K\u00f6ttgen","year":"2010","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib284","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1113\/jphysiol.2002.021170","article-title":"Organic cation transporter mRNA and function in the rat superior cervical ganglion","volume":"543","author":"Kristufek","year":"2002","journal-title":"J Physiol"},{"key":"10.1124\/pr.118.015578_bib285","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1073\/pnas.1324141111","article-title":"Structure of sugar-bound LacY","volume":"111","author":"Kumar","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib286","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/clpt.2011.36","article-title":"Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects","volume":"89","author":"Kusuhara","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib287","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.1002\/art.21244","article-title":"Failure to confirm association between SLC22A4 polymorphism and rheumatoid arthritis in a Japanese population","volume":"52","author":"Kuwahara","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1124\/pr.118.015578_bib288","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1152\/physrev.00042.2006","article-title":"Catecholaminergic systems in stress: structural and molecular genetic approaches","volume":"89","author":"Kvetnansky","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1124\/pr.118.015578_bib289","doi-asserted-by":"crossref","first-page":"16965","DOI":"10.1038\/s41598-018-35322-6","article-title":"OCT3 promoter haplotype is associated with metformin pharmacokinetics in Koreans","volume":"8","author":"Kwon","year":"2018","journal-title":"Sci Rep"},{"key":"10.1124\/pr.118.015578_bib290","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1002\/ajmg.10585","article-title":"Novel OCTN2 mutations: no genotype-phenotype correlations: early carnitine therapy prevents cardiomyopathy","volume":"111","author":"Lamhonwah","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1124\/pr.118.015578_bib291","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/S0306-4522(96)00604-5","article-title":"Increased sodium appetite stimulates c-fos expression in the organum vasculosum of the lamina terminalis","volume":"78","author":"Lane","year":"1997","journal-title":"Neuroscience"},{"key":"10.1124\/pr.118.015578_bib292","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1124\/mol.108.052381","article-title":"The role of the mammalian copper transporter 1 in the cellular accumulation of platinum-based drugs","volume":"75","author":"Larson","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib293","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s10038-003-0015-5","article-title":"Genetic variability of the extraneuronal monoamine transporter EMT (SLC22A3)","volume":"48","author":"Lazar","year":"2003","journal-title":"J Hum Genet"},{"key":"10.1124\/pr.118.015578_bib294","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S1461145707007742","article-title":"Novel mutations of the extraneuronal monoamine transporter gene in children and adolescents with obsessive-compulsive disorder","volume":"11","author":"Lazar","year":"2008","journal-title":"Int J Neuropsychopharmacol"},{"key":"10.1124\/pr.118.015578_bib295","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00008571-200207000-00007","article-title":"Polymorphisms in a human kidney xenobiotic transporter, OCT2, exhibit altered function","volume":"12","author":"Leabman","year":"2002","journal-title":"Pharmacogenetics"},{"key":"10.1124\/pr.118.015578_bib296","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1124\/dmd.115.068163","article-title":"Impact of experimental conditions on the evaluation of interactions between multidrug and toxin extrusion proteins and candidate drugs","volume":"44","author":"Lechner","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib297","doi-asserted-by":"crossref","first-page":"9690","DOI":"10.1021\/jf500916d","article-title":"Multidrug and toxic compound extrusion protein-1 (MATE1\/SLC47A1) is a novel flavonoid transporter","volume":"62","author":"Lee","year":"2014","journal-title":"J Agric Food Chem"},{"key":"10.1124\/pr.118.015578_bib298","doi-asserted-by":"crossref","first-page":"27055","DOI":"10.1074\/jbc.M114.570564","article-title":"Taste of a pill: organic cation transporter-3 (OCT3) mediates metformin accumulation and secretion in salivary glands","volume":"289","author":"Lee","year":"2014","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib300","doi-asserted-by":"crossref","first-page":"F1504","DOI":"10.1152\/ajprenal.90754.2008","article-title":"Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule","volume":"296","author":"Lee","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib301","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ki.2014.66","article-title":"Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat","volume":"86","author":"Lepist","year":"2014","journal-title":"Kidney Int"},{"key":"10.1124\/pr.118.015578_bib302","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1086\/339432","article-title":"CARD15\/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease","volume":"70","author":"Lesage","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1124\/pr.118.015578_bib303","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1440-1711.2006.01423.x","article-title":"Polymorphisms in the organic cation transporter genes SLC22A4 and SLC22A5 and Crohn\u2019s disease in a New Zealand Caucasian cohort","volume":"84","author":"Leung","year":"2006","journal-title":"Immunol Cell Biol"},{"key":"10.1124\/pr.118.015578_bib304","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1124\/dmd.109.028035","article-title":"Differential regulation of drug transporter expression by hepatocyte growth factor in primary human hepatocytes","volume":"37","author":"Le Vee","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib305","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.me.39.020188.002341","article-title":"Serum creatinine and renal function","volume":"39","author":"Levey","year":"1988","journal-title":"Annu Rev Med"},{"key":"10.1124\/pr.118.015578_bib306","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.7906055","article-title":"Agmatine: an endogenous clonidine-displacing substance in the brain","volume":"263","author":"Li","year":"1994","journal-title":"Science"},{"key":"10.1124\/pr.118.015578_bib307","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1124\/dmd.113.056689","article-title":"The contribution of human OCT1, OCT3, and CYP3A4 to nitidine chloride-induced hepatocellular toxicity","volume":"42","author":"Li","year":"2014","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib308","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/bdd.2104","article-title":"Multiple organic cation transporters contribute to the renal transport of sulpiride","volume":"38","author":"Li","year":"2017","journal-title":"Biopharm Drug Dispos"},{"key":"10.1124\/pr.118.015578_bib309","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1021\/mp200395f","article-title":"Deficiency of multidrug and toxin extrusion 1 enhances renal accumulation of paraquat and deteriorates kidney injury in mice","volume":"8","author":"Li","year":"2011","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib310","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1021\/mp400013t","article-title":"Ischemia\/Reperfusion-inducible protein modulates the function of organic cation transporter 1 and multidrug and toxin extrusion 1","volume":"10","author":"Li","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib311","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.npp.1300439","article-title":"In vivo regulation of glycogen synthase kinase-3beta (GSK3beta) by serotonergic activity in mouse brain","volume":"29","author":"Li","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.118.015578_bib312","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2002907","article-title":"Organic cation transporter 1 (OCT1) modulates multiple cardiometabolic traits through effects on hepatic thiamine content","volume":"16","author":"Liang","year":"2018","journal-title":"PLoS Biol"},{"key":"10.1124\/pr.118.015578_bib313","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s10620-012-2424-9","article-title":"Long-term cisplatin exposure promotes methylation of the OCT1 gene in human esophageal cancer cells","volume":"58","author":"Lin","year":"2013","journal-title":"Dig Dis Sci"},{"key":"10.1124\/pr.118.015578_bib314","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1165\/rcmb.2004-0363OC","article-title":"Polyspecific cation transporters mediate luminal release of acetylcholine from bronchial epithelium","volume":"33","author":"Lips","year":"2005","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1124\/pr.118.015578_bib315","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1016\/j.eururo.2006.10.028","article-title":"Acetylcholine and molecular components of its synthesis and release machinery in the urothelium","volume":"51","author":"Lips","year":"2007","journal-title":"Eur Urol"},{"key":"10.1124\/pr.118.015578_bib316","doi-asserted-by":"crossref","first-page":"e4993","DOI":"10.1097\/MD.0000000000004993","article-title":"Efficacy and safety of the oxaliplatin-based chemotherapy in the treatment of advanced primary hepatocellular carcinoma: a meta-analysis of prospective studies","volume":"95","author":"Liu","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1124\/pr.118.015578_bib317","doi-asserted-by":"crossref","first-page":"348ra97","DOI":"10.1126\/scitranslmed.aaf3124","article-title":"Epigenetic activation of the drug transporter OCT2 sensitizes renal cell carcinoma to oxaliplatin","volume":"8","author":"Liu","year":"2016","journal-title":"Sci Transl Med"},{"issue":"Suppl 3","key":"10.1124\/pr.118.015578_bib318","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1159\/000448321","article-title":"Primary carnitine deficiency and newborn screening for disorders of the carnitine cycle","volume":"68","author":"Longo","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"10.1124\/pr.118.015578_bib319","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.1016\/j.bbamcr.2016.01.023","article-title":"Carnitine transport and fatty acid oxidation","volume":"1863","author":"Longo","year":"2016","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib320","doi-asserted-by":"crossref","first-page":"8902","DOI":"10.1073\/pnas.0803441105","article-title":"cis-Diammine(pyridine)chloroplatinum(II), a monofunctional platinum(II) antitumor agent: uptake, structure, function, and prospects","volume":"105","author":"Lovejoy","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib321","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0378-1119(00)00014-7","article-title":"Role of the transcription factor AML-1 in acute leukemia and hematopoietic differentiation","volume":"245","author":"Lutterbach","year":"2000","journal-title":"Gene"},{"key":"10.1124\/pr.118.015578_bib322","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/dmd.116.073304","article-title":"Multiple SLC and ABC transporters contribute to the placental transfer of entecavir","volume":"45","author":"Ma","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib323","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/nature13270","article-title":"Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase","volume":"510","author":"Madiraju","year":"2014","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib324","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00054725-200002000-00004","article-title":"The key role of macrophages in the immunopathogenesis of inflammatory bowel disease","volume":"6","author":"Mahida","year":"2000","journal-title":"Inflamm Bowel Dis"},{"key":"10.1124\/pr.118.015578_bib325","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/325641a0","article-title":"Mammalian and bacterial sugar transport proteins are homologous","volume":"325","author":"Maiden","year":"1987","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib326","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1056-8727(03)00091-6","article-title":"Carnitine deficiency in children and adolescents with type 1 diabetes","volume":"18","author":"Mamoulakis","year":"2004","journal-title":"J Diabetes Complications"},{"key":"10.1124\/pr.118.015578_bib327","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1200\/JCO.2009.26.3087","article-title":"Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib","volume":"28","author":"Marin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1124\/pr.118.015578_bib328","doi-asserted-by":"crossref","first-page":"4437","DOI":"10.1182\/blood-2008-06-162388","article-title":"European LeukemiaNet criteria for failure or suboptimal response reliably identify patients with CML in early chronic phase treated with imatinib whose eventual outcome is poor","volume":"112","author":"Marin","year":"2008","journal-title":"Blood"},{"key":"10.1124\/pr.118.015578_bib329","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.freeradbiomed.2009.01.021","article-title":"Skin cells and tissue are capable of using L-ergothioneine as an integral component of their antioxidant defense system","volume":"46","author":"Markova","year":"2009","journal-title":"Free Radic Biol Med"},{"key":"10.1124\/pr.118.015578_bib330","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s002100100476","article-title":"Regulation of human extraneuronal monoamine transporter (hEMT) expressed in HEK293 cells by intracellular second messenger systems","volume":"364","author":"Martel","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.118.015578_bib331","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/sj.ejhg.5201529","article-title":"Association of the organic cation transporter OCTN genes with Crohn\u2019s disease in the Spanish population","volume":"14","author":"Mart\u00ednez","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"10.1124\/pr.118.015578_bib332","first-page":"842","article-title":"Role of SLC22A4, SLC22A5, and RUNX1 genes in rheumatoid arthritis","volume":"33","author":"Mart\u00ednez","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1124\/pr.118.015578_bib333","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1124\/mol.116.105056","article-title":"Lack of influence of substrate on ligand interaction with the human multidrug and toxin extruder, MATE1","volume":"90","author":"Mart\u00ednez-Guerrero","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib334","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1124\/jpet.113.204206","article-title":"Substrate-dependent inhibition of human MATE1 by cationic ionic liquids","volume":"346","author":"Mart\u00ednez-Guerrero","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib335","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s00424-013-1335-8","article-title":"The organic cation transporter 3 (OCT3) as molecular target of psychotropic drugs: transport characteristics and acute regulation of cloned murine OCT3","volume":"466","author":"Massmann","year":"2014","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.118.015578_bib336","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1681\/ASN.2006030205","article-title":"Identification and functional characterization of a new human kidney-specific H+\/organic cation antiporter, kidney-specific multidrug and toxin extrusion 2","volume":"17","author":"Masuda","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.118.015578_bib337","doi-asserted-by":"crossref","first-page":"4252","DOI":"10.1021\/mp400341t","article-title":"Combined in vitro-in vivo approach to assess the hepatobiliary disposition of a novel oral thrombin inhibitor","volume":"10","author":"Matsson","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib338","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1124\/dmd.108.023911","article-title":"The inhibition of human multidrug and toxin extrusion 1 is involved in the drug-drug interaction caused by cimetidine","volume":"37","author":"Matsushima","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib339","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1002\/cpt.317","article-title":"OCT1 mediates hepatic uptake of sumatriptan and loss-of-function OCT1 polymorphisms affect sumatriptan pharmacokinetics","volume":"99","author":"Matthaei","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib340","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cpt.1128","article-title":"OCT1 deficiency affects hepatocellular concentrations and pharmacokinetics of cycloguanil, the active metabolite of the antimalarial drug proguanil","volume":"105","author":"Matthaei","year":"2019","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib341","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1038\/s41386-018-0053-5","article-title":"An unsuspected role for organic cation transporter 3 in the actions of amphetamine","volume":"43","author":"Mayer","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1124\/pr.118.015578_bib342","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/FJC.0b013e3181abc288","article-title":"The organic cation transporter, OCTN1, expressed in the human heart, potentiates antagonism of the HERG potassium channel","volume":"54","author":"McBride","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.118.015578_bib343","first-page":"F532","article-title":"Procainamide transport in rabbit renal cortical brush border membrane vesicles","volume":"249","author":"McKinney","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.118.015578_bib344","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1681\/ASN.V1171216","article-title":"The affinity of the organic cation transporter rOCT1 is increased by protein kinase C-dependent phosphorylation","volume":"11","author":"Mehrens","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.118.015578_bib345","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/dmd.106.013342","article-title":"Regional distribution of solute carrier mRNA expression along the human intestinal tract","volume":"35","author":"Meier","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib346","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1006\/bbrc.1998.9034","article-title":"Membrane localization of the electrogenic cation transporter rOCT1 in rat liver","volume":"248","author":"Meyer-Wentrup","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib347","doi-asserted-by":"crossref","first-page":"F997","DOI":"10.1152\/ajprenal.00431.2009","article-title":"Human multidrug and toxin extrusion 1 (MATE1\/SLC47A1) transporter: functional characterization, interaction with OCT2 (SLC22A2), and single nucleotide polymorphisms","volume":"298","author":"Meyer zu Schwabedissen","year":"2010","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib348","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1038\/nature11808","article-title":"Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP","volume":"494","author":"Miller","year":"2013","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib349","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1158\/1535-7163.MCT-10-0731","article-title":"Interactions of tyrosine kinase inhibitors with organic cation transporters and multidrug and toxic compound extrusion proteins","volume":"10","author":"Minematsu","year":"2011","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/pr.118.015578_bib350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/dmd.109.028142","volume":"38","author":"Minematsu","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib351","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1124\/dmd.108.024083","article-title":"Transport of dicationic drugs pentamidine and furamidine by human organic cation transporters","volume":"37","author":"Ming","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib352","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1124\/jpet.107.131482","article-title":"Expression and functionality of anti-human immunodeficiency virus and anticancer drug uptake transporters in immune cells","volume":"324","author":"Minuesa","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib353","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1124\/jpet.108.146225","article-title":"Transport of lamivudine [(-)-\u03b2-L-2\u2032,3\u2032-dideoxy-3\u2032-thiacytidine] and high-affinity interaction of nucleoside reverse transcriptase inhibitors with human organic cation transporters 1, 2, and 3","volume":"329","author":"Minuesa","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib354","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1021\/acs.molpharmaceut.5b00733","article-title":"The nonmetabolized \u03b2-blocker nadolol is a substrate of OCT1, OCT2, MATE1, MATE2-K, and P-glycoprotein, but not of OATP1B1 and OATP1B3","volume":"13","author":"Misaka","year":"2016","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib355","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.xphs.2017.04.067","article-title":"Involvement of organic cation transporters in the kinetics of trimethylamine N-oxide","volume":"106","author":"Miyake","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib356","doi-asserted-by":"crossref","first-page":"6623","DOI":"10.1073\/pnas.0511031103","article-title":"Limited evolutionary conservation of imprinting in the human placenta","volume":"103","author":"Monk","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib357","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1158\/1535-7163.MCT-06-0500","article-title":"Potent cytotoxicity of the phosphatase inhibitor microcystin LR and microcystin analogues in OATP1B1- and OATP1B3-expressing HeLa cells","volume":"6","author":"Monks","year":"2007","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/pr.118.015578_bib358","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1124\/dmd.115.068577","article-title":"Proteomic analysis of the developmental trajectory of human hepatic membrane transporter proteins in the first three months of life","volume":"44","author":"Mooij","year":"2016","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib359","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1158\/1535-7163.MCT-09-1084","article-title":"Organic cation transporters modulate the uptake and cytotoxicity of picoplatin, a third-generation platinum analogue","volume":"9","author":"More","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/pr.118.015578_bib360","doi-asserted-by":"crossref","first-page":"168","DOI":"10.2337\/db10-0805","article-title":"OCT1 expression in adipocytes could contribute to increased metformin action in obese subjects","volume":"60","author":"Moreno-Navarrete","year":"2011","journal-title":"Diabetes"},{"key":"10.1124\/pr.118.015578_bib361","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/00498250701883753","article-title":"Multidrug and toxic compound extrusion (MATE)-type proteins as anchor transporters for the excretion of metabolic waste products and xenobiotics","volume":"38","author":"Moriyama","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/pr.118.015578_bib362","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fphar.2015.00078","article-title":"Interactions of antiretroviral drugs with the SLC22A1 (OCT1) drug transporter","volume":"6","author":"Moss","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1124\/pr.118.015578_bib363","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/jps.23567","article-title":"Precise comparison of protein localization among OCT, OAT, and MATE in human kidney","volume":"102","author":"Motohashi","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib364","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","article-title":"Gene expression levels and immunolocalization of organic ion transporters in the human kidney","volume":"13","author":"Motohashi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"10.1124\/pr.118.015578_bib365","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/AAC.01835-10","article-title":"Molecular mechanism of renal tubular secretion of the antimalarial drug chloroquine","volume":"55","author":"M\u00fcller","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.118.015578_bib366","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1021\/acs.molpharmaceut.8b00416","article-title":"Importance of OCT2 and MATE1 for the cimetidine-metformin interaction: insights from investigations of polarized transport in single- and double-transfected MDCK cells with a focus on perpetrator disposition","volume":"15","author":"M\u00fcller","year":"2018","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib367","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1016\/j.bcp.2005.09.011","article-title":"Drug specificity and intestinal membrane localization of human organic cation transporters (OCT)","volume":"70","author":"M\u00fcller","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib368","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.2337\/diabetes.51.7.2074","article-title":"Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes","volume":"51","author":"Musi","year":"2002","journal-title":"Diabetes"},{"key":"10.1124\/pr.118.015578_bib369","doi-asserted-by":"crossref","first-page":"31953","DOI":"10.1074\/jbc.272.51.31953","article-title":"A reevaluation of substrate specificity of the rat cation transporter rOCT1","volume":"272","author":"Nagel","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib370","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1002\/jps.23595","article-title":"Involvement of carnitine\/organic cation transporter OCTN1\/SLC22A4 in gastrointestinal absorption of metformin","volume":"102","author":"Nakamichi","year":"2013","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib371","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1021\/mp900206j","article-title":"Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation\/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption","volume":"7","author":"Nakamura","year":"2010","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib372","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/j.bcp.2010.08.019","article-title":"Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity","volume":"80","author":"Nakamura","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib373","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.brainres.2007.09.072","article-title":"The role of organic cation transporter-3 in methamphetamine disposition and its behavioral response in rats","volume":"1184","author":"Nakayama","year":"2007","journal-title":"Brain Res"},{"key":"10.1124\/pr.118.015578_bib374","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0892-0362(02)00211-8","article-title":"Dopamine-derived endogenous N-methyl-(R)-salsolinol: its role in Parkinson\u2019s disease","volume":"24","author":"Naoi","year":"2002","journal-title":"Neurotoxicol Teratol"},{"key":"10.1124\/pr.118.015578_bib375","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1159\/000336610","article-title":"Pretherapeutic expression of the hOCT1 gene predicts a complete molecular response to imatinib mesylate in chronic-phase chronic myeloid leukemia","volume":"127","author":"Nardinelli","year":"2012","journal-title":"Acta Haematol"},{"key":"10.1124\/pr.118.015578_bib376","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S0005-2728(00)00247-4","article-title":"UCP1: the only protein able to mediate adaptive non-shivering thermogenesis and metabolic inefficiency","volume":"1504","author":"Nedergaard","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib377","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1023\/A:1025032511040","article-title":"pH-dependent bidirectional transport of weakly basic drugs across Caco-2 monolayers: implications for drug-drug interactions","volume":"20","author":"Neuhoff","year":"2003","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib378","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1053\/j.gastro.2004.11.056","article-title":"A risk haplotype in the Solute Carrier Family 22A4\/22A5 gene cluster influences phenotypic expression of Crohn\u2019s disease","volume":"128","author":"Newman","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1124\/pr.118.015578_bib379","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1572-0241.2004.04038.x","article-title":"CARD15 and HLA DRB1 alleles influence susceptibility and disease localization in Crohn\u2019s disease","volume":"99","author":"Newman","year":"2004","journal-title":"Am J Gastroenterol"},{"key":"10.1124\/pr.118.015578_bib380","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/art.20854","article-title":"SLC22A4 polymorphisms implicated in rheumatoid arthritis and Crohn\u2019s disease are not associated with rheumatoid arthritis in a Canadian Caucasian population","volume":"52","author":"Newman","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1124\/pr.118.015578_bib381","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/emboj.2010.309","article-title":"Crystal structure of a prokaryotic homologue of the mammalian oligopeptide-proton symporters, PepT1 and PepT2","volume":"30","author":"Newstead","year":"2011","journal-title":"EMBO J"},{"key":"10.1124\/pr.118.015578_bib382","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/5030","article-title":"Primary systemic carnitine deficiency is caused by mutations in a gene encoding sodium ion-dependent carnitine transporter","volume":"21","author":"Nezu","year":"1999","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib383","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1007\/s00204-016-1728-5","article-title":"Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine","volume":"90","author":"Nies","year":"2016","journal-title":"Arch Toxicol"},{"key":"10.1124\/pr.118.015578_bib384","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00210-007-0219-x","article-title":"Vectorial transport of the plant alkaloid berberine by double-transfected cells expressing the human organic cation transporter 1 (OCT1, SLC22A1) and the efflux pump MDR1 P-glycoprotein (ABCB1)","volume":"376","author":"Nies","year":"2008","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.118.015578_bib385","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022163","article-title":"Proton pump inhibitors inhibit metformin uptake by organic cation transporters (OCTs)","volume":"6","author":"Nies","year":"2011","journal-title":"PLoS One"},{"key":"10.1124\/pr.118.015578_bib386","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-3-642-14541-4_3","article-title":"Organic cation transporters (OCTs, MATEs), in vitro and in vivo evidence for the importance in drug therapy","volume":"201","author":"Nies","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1124\/pr.118.015578_bib387","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/hep.23103","article-title":"Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver","volume":"50","author":"Nies","year":"2009","journal-title":"Hepatology"},{"key":"10.1124\/pr.118.015578_bib388","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1158\/1078-0432.CCR-13-1999","article-title":"Cellular uptake of imatinib into leukemic cells is independent of human organic cation transporter 1 (OCT1)","volume":"20","author":"Nies","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1124\/pr.118.015578_bib389","doi-asserted-by":"crossref","first-page":"452","DOI":"10.2133\/dmpk.20.452","article-title":"Tissue-specific mRNA expression profiles of human ATP-binding cassette and solute carrier transporter superfamilies","volume":"20","author":"Nishimura","year":"2005","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib390","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1056\/NEJMoa022457","article-title":"Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia","volume":"348","author":"O\u2019Brien","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.118.015578_bib391","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1124\/jpet.113.206359","article-title":"Hepatocyte nuclear factor 1 regulates the expression of the organic cation transporter 1 via binding to an evolutionary conserved region in intron 1 of the OCT1 gene","volume":"347","author":"O\u2019Brien","year":"2013","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib392","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1124\/jpet.102.036004","article-title":"Studies on functional sites of organic cation\/carnitine transporter OCTN2 (SLC22A5) using a Ser467Cys mutant protein","volume":"302","author":"Ohashi","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib393","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0026-895X(24)12847-7","article-title":"Molecular and physiological evidence for multifunctionality of carnitine\/organic cation transporter OCTN2","volume":"59","author":"Ohashi","year":"2001","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib394","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S0022-3565(24)35167-5","article-title":"Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance","volume":"291","author":"Ohashi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib395","doi-asserted-by":"crossref","first-page":"293","DOI":"10.2133\/dmpk.23.293","article-title":"Role of Na+\/L-carnitine transporter (OCTN2) in renal handling of pivaloylcarnitine and valproylcarnitine formed during pivalic acid-containing prodrugs and valproic acid treatment","volume":"23","author":"Ohnishi","year":"2008","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib396","doi-asserted-by":"crossref","first-page":"388","DOI":"10.18433\/J3R59X","article-title":"Functional characteristics of two human MATE transporters: kinetics of cimetidine transport and profiles of inhibition by various compounds","volume":"12","author":"Ohta","year":"2009","journal-title":"J Pharm Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib397","first-page":"2129","article-title":"Genome-wide analysis of gene expression in human hepatocellular carcinomas using cDNA microarray: identification of genes involved in viral carcinogenesis and tumor progression","volume":"61","author":"Okabe","year":"2001","journal-title":"Cancer Res"},{"key":"10.1124\/pr.118.015578_bib398","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1158\/1535-7163.MCT-08-0539","article-title":"Profiling SLCO and SLC22 genes in the NCI-60 cancer cell lines to identify drug uptake transporters","volume":"7","author":"Okabe","year":"2008","journal-title":"Mol Cancer Ther"},{"key":"10.1124\/pr.118.015578_bib399","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2133\/dmpk.21.432","article-title":"Interactions of fluoroquinolone antibacterials, DX-619 and levofloxacin, with creatinine transport by renal organic cation transporter hOCT2","volume":"21","author":"Okuda","year":"2006","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib400","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1006\/bbrc.1996.1056","article-title":"cDNA cloning and functional expression of a novel rat kidney organic cation transporter, OCT2","volume":"224","author":"Okuda","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib401","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S0005-2736(99)00005-X","article-title":"Molecular mechanisms of organic cation transport in OCT2-expressing Xenopus oocytes","volume":"1417","author":"Okuda","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib402","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/S0014-5793(00)02134-7","article-title":"Functional characterization of the human high-affinity choline transporter","volume":"484","author":"Okuda","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.118.015578_bib403","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1128\/AAC.37.5.1056","article-title":"Pyrimethamine inhibits renal secretion of creatinine","volume":"37","author":"Opravil","year":"1993","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.118.015578_bib404","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/clpt.1990.2","article-title":"Morphine and metabolite behavior after different routes of morphine administration: demonstration of the importance of the active metabolite morphine-6-glucuronide","volume":"47","author":"Osborne","year":"1990","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib405","doi-asserted-by":"crossref","first-page":"17923","DOI":"10.1073\/pnas.0506483102","article-title":"A human transporter protein that mediates the final excretion step for toxic organic cations","volume":"102","author":"Otsuka","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib406","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/BF00180294","article-title":"The metabolism of tramadol by human liver microsomes","volume":"70","author":"Paar","year":"1992","journal-title":"Clin Investig"},{"key":"10.1124\/pr.118.015578_bib407","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"10.1124\/pr.118.015578_bib408","doi-asserted-by":"crossref","first-page":"F505","DOI":"10.1152\/ajprenal.90545.2008","article-title":"The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity","volume":"296","author":"Pabla","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib409","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S0006-3495(98)77529-0","article-title":"A helix propensity scale based on experimental studies of peptides and proteins","volume":"75","author":"Pace","year":"1998","journal-title":"Biophys J"},{"key":"10.1124\/pr.118.015578_bib410","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2036.2006.02780.x","article-title":"Variants of OCTN1-2 cation transporter genes are associated with both Crohn\u2019s disease and ulcerative colitis","volume":"23","author":"Palmieri","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib411","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/MMBR.62.1.1-34.1998","article-title":"Major facilitator superfamily","volume":"62","author":"Pao","year":"1998","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1124\/pr.118.015578_bib412","first-page":"62","article-title":"Comprehensive substrate characterization of 22 antituberculosis drugs for multiple solute carrier (SLC) uptake transporters, in vitro","volume":"27","author":"Parvez","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.118.015578_bib413","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1176\/ajp.152.1.76","article-title":"A family study of obsessive-compulsive disorder","volume":"152","author":"Pauls","year":"1995","journal-title":"Am J Psychiatry"},{"key":"10.1124\/pr.118.015578_bib414","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/nature12042","article-title":"Crystal structure of a eukaryotic phosphate transporter","volume":"496","author":"Pedersen","year":"2013","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib415","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1007\/s00228-006-0135-x","article-title":"Enantioselective pharmacokinetics of tramadol in CYP2D6 extensive and poor metabolizers","volume":"62","author":"Pedersen","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib416","doi-asserted-by":"crossref","first-page":"F313","DOI":"10.1152\/ajprenal.00038.2012","article-title":"Functional significance of conserved cysteines in the human organic cation transporter 2","volume":"303","author":"Pelis","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib417","doi-asserted-by":"crossref","first-page":"35272","DOI":"10.1074\/jbc.M606561200","article-title":"Cysteine accessibility in the hydrophilic cleft of human organic cation transporter 2","volume":"281","author":"Pelis","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib418","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1038\/ng1339","article-title":"Functional variants of OCTN cation transporter genes are associated with Crohn disease","volume":"36","author":"Peltekova","year":"2004","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib419","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3389\/fendo.2015.00174","article-title":"Unlock the thermogenic potential of adipose tissue: pharmacological modulation and implications for treatment of diabetes and obesity","volume":"6","author":"Peng","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1124\/pr.118.015578_bib420","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF00562061","article-title":"Pharmacokinetics of metformin after intravenous and oral administration to man","volume":"16","author":"Pentik\u00e4inen","year":"1979","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib421","doi-asserted-by":"crossref","first-page":"33741","DOI":"10.1074\/jbc.M104617200","article-title":"Properties and regulation of organic cation transport in freshly isolated human proximal tubules","volume":"276","author":"Pietig","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib422","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1177\/2472555218812821","article-title":"OCTN: a small transporter subfamily with great relevance to human pathophysiology, drug discovery, and diagnostics","volume":"24","author":"Pochini","year":"2019","journal-title":"SLAS Discov"},{"key":"10.1124\/pr.118.015578_bib423","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.bbamem.2011.12.014","article-title":"The human OCTN1 (SLC22A4) reconstituted in liposomes catalyzes acetylcholine transport which is defective in the mutant L503F associated to the Crohn\u2019s disease","volume":"1818","author":"Pochini","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib424","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.intimp.2015.04.040","article-title":"Immuno-detection of OCTN1 (SLC22A4) in HeLa cells and characterization of transport function","volume":"29","author":"Pochini","year":"2015","journal-title":"Int Immunopharmacol"},{"key":"10.1124\/pr.118.015578_bib425","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1124\/mol.104.008839","article-title":"Amino acids critical for substrate affinity of rat organic cation transporter 1 line the substrate binding region in a model derived from the tertiary structure of lactose permease","volume":"67","author":"Popp","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib426","doi-asserted-by":"crossref","unstructured":"Porsolt RD, Brossard G, Hautbois C, Roux S (2001) Rodent models of depression: forced swimming and tail suspension behavioral despair tests in rats and mice. Curr Protoc Neurosci Chapter 8:Unit 8.10A.","DOI":"10.1002\/0471141755.ph0508s10"},{"key":"10.1124\/pr.118.015578_bib427","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1007\/s004310050732","article-title":"Acquired carnitine abnormalities in critically ill children","volume":"156","author":"Proulx","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1124\/pr.118.015578_bib428","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0076474","article-title":"Different involvement of promoter methylation in the expression of organic cation\/carnitine transporter 2 (OCTN2) in cancer cell lines","volume":"8","author":"Qu","year":"2013","journal-title":"PLoS One"},{"key":"10.1124\/pr.118.015578_bib429","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1016\/0024-3205(95)00226-V","article-title":"Agmatine, the bacterial amine, is widely distributed in mammalian tissues","volume":"56","author":"Raasch","year":"1995","journal-title":"Life Sci"},{"key":"10.1124\/pr.118.015578_bib430","first-page":"218","article-title":"Testicular cancer: maintaining the high cure rate","volume":"17","author":"Raghavan","year":"2003","journal-title":"Oncology (Williston Park)"},{"key":"10.1124\/pr.118.015578_bib431","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1124\/dmd.112.048918","article-title":"In vitro investigations into the roles of drug transporters and metabolizing enzymes in the disposition and drug interactions of dolutegravir, a HIV integrase inhibitor","volume":"41","author":"Reese","year":"2013","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib432","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S0005-2736(02)00341-3","article-title":"Expression and promoter analysis of SLC19A2 in the human intestine","volume":"1561","author":"Reidling","year":"2002","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib433","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: old or new insights?","volume":"56","author":"Rena","year":"2013","journal-title":"Diabetologia"},{"key":"10.1124\/pr.118.015578_bib434","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00498254.2016.1158886","article-title":"Emtricitabine is a substrate of MATE1 but not of OCT1, OCT2, P-gp, BCRP or MRP2 transporters","volume":"47","author":"Reznicek","year":"2017","journal-title":"Xenobiotica"},{"key":"10.1124\/pr.118.015578_bib435","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1476-5586(04)80047-2","article-title":"ONCOMINE: a cancer microarray database and integrated data-mining platform","volume":"6","author":"Rhodes","year":"2004","journal-title":"Neoplasia"},{"key":"10.1124\/pr.118.015578_bib436","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.mrgentox.2010.07.008","article-title":"Prevention by L-carnitine of DNA damage induced by propionic and L-methylmalonic acids in human peripheral leukocytes in vitro","volume":"702","author":"Ribas","year":"2010","journal-title":"Mutat Res"},{"key":"10.1124\/pr.118.015578_bib437","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/ng1001-223","article-title":"Genetic variation in the 5q31 cytokine gene cluster confers susceptibility to Crohn disease","volume":"29","author":"Rioux","year":"2001","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib438","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1289\/ehp.0800277","article-title":"Dopamine transporter genetic variants and pesticides in Parkinson\u2019s disease","volume":"117","author":"Ritz","year":"2009","journal-title":"Environ Health Perspect"},{"key":"10.1124\/pr.118.015578_bib439","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/00007691-198712000-00003","article-title":"Interaction of steady-state procainamide with H2-receptor antagonists cimetidine and ranitidine","volume":"9","author":"Rodvold","year":"1987","journal-title":"Ther Drug Monit"},{"key":"10.1124\/pr.118.015578_bib440","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What we talk about when we talk about fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"10.1124\/pr.118.015578_bib441","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1476-5381.2011.01724.x","article-title":"OATPs, OATs and OCTs: the organic anion and cation transporters of the SLCO and SLC22A gene superfamilies","volume":"165","author":"Roth","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib442","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nprot.2010.5","article-title":"I-TASSER: a unified platform for automated protein structure and function prediction","volume":"5","author":"Roy","year":"2010","journal-title":"Nat Protoc"},{"key":"10.1124\/pr.118.015578_bib443","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1016\/S1734-1140(13)71491-9","article-title":"Glucocorticoid receptor regulates organic cation transporter 1 (OCT1, SLC22A1) expression via HNF4\u03b1 upregulation in primary human hepatocytes","volume":"65","author":"Rulcova","year":"2013","journal-title":"Pharmacol Rep"},{"key":"10.1124\/pr.118.015578_bib444","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/gut.2005.082107","article-title":"Analysis of the influence of OCTN1\/2 variants within the IBD5 locus on disease susceptibility and growth indices in early onset inflammatory bowel disease","volume":"55","author":"Russell","year":"2006","journal-title":"Gut"},{"key":"10.1124\/pr.118.015578_bib445","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.bcp.2012.01.032","article-title":"The prototypic pharmacogenetic drug debrisoquine is a substrate of the genetically polymorphic organic cation transporter OCT1","volume":"83","author":"Saadatmand","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib446","series-title":"Organic Cation Transporters: Integration of Physiology, Pathology and Pharmacology","first-page":"217","article-title":"Translational relevance of animal models for the study of organic cation transporter function","author":"Saboli\u0107","year":"2016"},{"key":"10.1124\/pr.118.015578_bib447","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1124\/jpet.105.099929","article-title":"The human organic cation transporter-1 gene is transactivated by hepatocyte nuclear factor-4\u03b1","volume":"317","author":"Saborowski","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib448","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1542\/peds.2011-2607","article-title":"Race and unequal burden of perioperative pain and opioid related adverse effects in children","volume":"129","author":"Sadhasivam","year":"2012","journal-title":"Pediatrics"},{"key":"10.1124\/pr.118.015578_bib449","doi-asserted-by":"crossref","first-page":"217","DOI":"10.5055\/jom.2012.0119","article-title":"Morphine clearance in children: does race or genetics matter?","volume":"8","author":"Sadhasivam","year":"2012","journal-title":"J Opioid Manag"},{"key":"10.1124\/pr.118.015578_bib450","doi-asserted-by":"crossref","first-page":"13969","DOI":"10.1021\/bi035173q","article-title":"TetL tetracycline efflux protein from Bacillus subtilis is a dimer in the membrane and in detergent solution","volume":"42","author":"Safferling","year":"2003","journal-title":"Biochemistry"},{"key":"10.1124\/pr.118.015578_bib451","doi-asserted-by":"crossref","first-page":"G491","DOI":"10.1152\/ajpgi.00361.2003","article-title":"Expression and functional contribution of hTHTR-2 in thiamin absorption in human intestine","volume":"286","author":"Said","year":"2004","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1124\/pr.118.015578_bib453","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1002\/jps.22595","article-title":"Interindividual differences in placental expression of the SLC22A2 (OCT2) gene: relationship to epigenetic variations in the 5\u2032-upstream regulatory region","volume":"100","author":"Saito","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib454","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1254\/jphs.09331SC","article-title":"Functional analysis of human organic cation transporter OCT3 (SLC22A3) polymorphisms","volume":"113","author":"Sakata","year":"2010","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/pr.118.015578_bib455","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.bbrc.2003.11.175","article-title":"Novel single nucleotide polymorphisms of organic cation transporter 1 (SLC22A1) affecting transport functions","volume":"313","author":"Sakata","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib456","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1021\/mp500854e","article-title":"Beta-2 adrenergic agonists are substrates and inhibitors of human organic cation transporter 1","volume":"12","author":"Salomon","year":"2015","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib457","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1124\/mol.66.1.25","article-title":"Modulation of the cellular pharmacology of cisplatin and its analogs by the copper exporters ATP7A and ATP7B","volume":"66","author":"Samimi","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib458","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1124\/mol.117.111443","article-title":"Assessment of substrate-dependent ligand interactions at the organic cation transporter OCT2 using six model substrates","volume":"94","author":"Sandoval","year":"2018","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib459","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2350-7-54","article-title":"Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study","volume":"7","author":"Santiago","year":"2006","journal-title":"BMC Med Genet"},{"key":"10.1124\/pr.118.015578_bib460","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1093\/annonc\/mdm576","article-title":"Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer","volume":"19","author":"Santini","year":"2008","journal-title":"Ann Oncol"},{"key":"10.1124\/pr.118.015578_bib461","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1124\/jpet.105.086827","article-title":"Functional analysis of organic cation transporter 3 expressed in human placenta","volume":"315","author":"Sata","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib462","doi-asserted-by":"crossref","first-page":"15313","DOI":"10.1074\/jbc.273.25.15313","article-title":"Agmatine suppresses proliferation by frameshift induction of antizyme and attenuation of cellular polyamine levels","volume":"273","author":"Satriano","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib463","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0024-3205(96)00459-6","article-title":"Localization of monoamine oxidases in human peripheral tissues","volume":"59","author":"Saura","year":"1996","journal-title":"Life Sci"},{"key":"10.1124\/pr.118.015578_bib464","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/gm298","article-title":"DNA methylation is associated with downregulation of the organic cation transporter OCT1 (SLC22A1) in human hepatocellular carcinoma","volume":"3","author":"Schaeffeler","year":"2011","journal-title":"Genome Med"},{"key":"10.1124\/pr.118.015578_bib465","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003088-199630050-00003","article-title":"Clinical pharmacokinetics of metformin","volume":"30","author":"Scheen","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib466","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0169-409X(02)00169-2","article-title":"Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview","volume":"55","author":"Schinkel","year":"2003","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1124\/pr.118.015578_bib467","series-title":"Organic Cation Transporters: Integration of Physiology, Pathology and Pharmacology","first-page":"139","article-title":"Physiological and pathophysiological regulation of transporters for organic cations","author":"Schlatter","year":"2016"},{"key":"10.1124\/pr.118.015578_bib468","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052247","article-title":"Transport mechanisms and their pathology-induced regulation govern tyrosine kinase inhibitor delivery in rheumatoid arthritis","volume":"7","author":"Schmidt-Lauber","year":"2012","journal-title":"PLoS One"},{"key":"10.1124\/pr.118.015578_bib469","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1007\/BF00496410","article-title":"Carnitine plasma concentrations in 353 metabolically healthy children","volume":"147","author":"Schmidt-Sommerfeld","year":"1988","journal-title":"Eur J Pediatr"},{"key":"10.1124\/pr.118.015578_bib470","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/jnr.10521","article-title":"Organic cation transporter capable of transporting serotonin is up-regulated in serotonin transporter-deficient mice","volume":"71","author":"Schmitt","year":"2003","journal-title":"J Neurosci Res"},{"key":"10.1124\/pr.118.015578_bib471","doi-asserted-by":"crossref","first-page":"F709","DOI":"10.1152\/ajprenal.90323.2008","article-title":"Charge-to-substrate ratio during organic cation uptake by rat OCT2 is voltage dependent and altered by exchange of glutamate 448 with glutamine","volume":"296","author":"Schmitt","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib472","doi-asserted-by":"crossref","first-page":"24481","DOI":"10.1074\/jbc.M414550200","article-title":"Alkali cation binding and permeation in the rat organic cation transporter rOCT2","volume":"280","author":"Schmitt","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib473","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/2047-783X-15-8-337","article-title":"In vitro chemosensitivity of head and neck cancer cell lines","volume":"15","author":"Schuler","year":"2010","journal-title":"Eur J Med Res"},{"key":"10.1124\/pr.118.015578_bib474","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13073-015-0172-0","article-title":"Global genetic analyses reveal strong inter-ethnic variability in the loss of activity of the organic cation transporter OCT1","volume":"7","author":"Seitz","year":"2015","journal-title":"Genome Med"},{"key":"10.1124\/pr.118.015578_bib475","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/bbrc.1998.9521","article-title":"Molecular cloning and characterization of high-affinity carnitine transporter from rat intestine","volume":"251","author":"Sekine","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib476","doi-asserted-by":"crossref","first-page":"33388","DOI":"10.1074\/jbc.274.47.33388","article-title":"Mutations in novel organic cation transporter (OCTN2), an organic cation\/carnitine transporter, with differential effects on the organic cation transport function and the carnitine transport function","volume":"274","author":"Seth","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib477","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1124\/jpet.117.242552","article-title":"Correlation between apparent substrate affinity and OCT2 transport turnover","volume":"362","author":"Severance","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib478","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1124\/jpet.116.238337","article-title":"Tenofovir disoproxil fumarate is not an inhibitor of human organic cation transporter 1","volume":"360","author":"Shen","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib479","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/sj.clpt.6100275","article-title":"Effect of genetic variation in the organic cation transporter 1, OCT1, on metformin pharmacokinetics","volume":"83","author":"Shu","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib480","doi-asserted-by":"crossref","first-page":"5902","DOI":"10.1073\/pnas.0730858100","article-title":"Evolutionary conservation predicts function of variants of the human organic cation transporter, OCT1","volume":"100","author":"Shu","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib481","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1172\/JCI30558","article-title":"Effect of genetic variation in the organic cation transporter 1 (OCT1) on metformin action","volume":"117","author":"Shu","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.118.015578_bib482","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1038\/sj.ejhg.5201756","article-title":"Refined genomic localization and ethnic differences observed for the IBD5 association with Crohn\u2019s disease","volume":"15","author":"Silverberg","year":"2007","journal-title":"Eur J Hum Genet"},{"key":"10.1124\/pr.118.015578_bib483","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/cpt1978246683","article-title":"Disposition of metformin (N,N-dimethylbiguanide) in man","volume":"24","author":"Sirtori","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib484","doi-asserted-by":"crossref","first-page":"2823","DOI":"10.1002\/1097-0142(19871201)60:11<2823::AID-CNCR2820601138>3.0.CO;2-C","article-title":"The protective potential of the combination of verapamil and cimetidine on cisplatin-induced nephrotoxicity in man","volume":"60","author":"Sleijfer","year":"1987","journal-title":"Cancer"},{"key":"10.1124\/pr.118.015578_bib485","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1124\/dmd.30.2.212","article-title":"Tissue distribution and renal developmental changes in rat organic cation transporter mRNA levels","volume":"30","author":"Slitt","year":"2002","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib486","doi-asserted-by":"crossref","first-page":"16504","DOI":"10.1073\/pnas.0708258104","article-title":"Sugar binding induces an outward facing conformation of LacY","volume":"104","author":"Smirnova","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib487","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/FJC.0b013e3182270783","article-title":"Organic cation transporter 3: expression in failing and nonfailing human heart and functional characterization","volume":"58","author":"Solbach","year":"2011","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1124\/pr.118.015578_bib488","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1038\/emboj.2012.157","article-title":"Alternating access mechanism in the POT family of oligopeptide transporters","volume":"31","author":"Solcan","year":"2012","journal-title":"EMBO J"},{"key":"10.1124\/pr.118.015578_bib489","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1056\/NEJM198210213071715","article-title":"Cimetidine reduces procainamide elimination","volume":"307","author":"Somogyi","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.118.015578_bib490","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2125.1987.tb03090.x","article-title":"Reduction of metformin renal tubular secretion by cimetidine in man","volume":"23","author":"Somogyi","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib491","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0090-9556(25)08743-4","article-title":"Renal tubular secretion of amiloride and its inhibition by cimetidine in humans and in an animal model","volume":"17","author":"Somogyi","year":"1989","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib492","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/clpt.2008.61","article-title":"Genetic variants of the organic cation transporter 2 influence the disposition of metformin","volume":"84","author":"Song","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib493","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1080\/00498250802130039","article-title":"Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes","volume":"38","author":"Song","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/pr.118.015578_bib494","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2006571","article-title":"Organic cation transporter 3 (Oct3) is a distinct catecholamines clearance route in adipocytes mediating the beiging of white adipose tissue","volume":"17","author":"Song","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1124\/pr.118.015578_bib495","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM199202203260801","article-title":"The use of beta-agonists and the risk of death and near death from asthma","volume":"326","author":"Spitzer","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.118.015578_bib496","doi-asserted-by":"crossref","first-page":"11199","DOI":"10.1073\/pnas.1305321110","article-title":"Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2","volume":"110","author":"Sprowl","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib497","doi-asserted-by":"crossref","first-page":"10880","DOI":"10.1038\/ncomms10880","article-title":"A phosphotyrosine switch regulates organic cation transporters","volume":"7","author":"Sprowl","year":"2016","journal-title":"Nat Commun"},{"key":"10.1124\/pr.118.015578_bib498","doi-asserted-by":"crossref","first-page":"59","DOI":"10.12659\/MSMBR.909124","article-title":"Imatinib affects the expression of SLC22A1 in a non-linear concentration-dependent manner within 24 hours","volume":"24","author":"Sreenivasan Tantuan","year":"2018","journal-title":"Med Sci Monit Basic Res"},{"key":"10.1124\/pr.118.015578_bib499","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3959(03)00212-4","article-title":"Impact of CYP2D6 genotype on postoperative tramadol analgesia","volume":"105","author":"Stamer","year":"2003","journal-title":"Pain"},{"key":"10.1124\/pr.118.015578_bib500","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1097\/j.pain.0000000000000662","article-title":"Loss-of-function polymorphisms in the organic cation transporter OCT1 are associated with reduced postoperative tramadol consumption","volume":"157","author":"Stamer","year":"2016","journal-title":"Pain"},{"key":"10.1124\/pr.118.015578_bib501","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/ana.410300512","article-title":"Chronic cardiomyopathy and weakness or acute coma in children with a defect in carnitine uptake","volume":"30","author":"Stanley","year":"1991","journal-title":"Ann Neurol"},{"key":"10.1124\/pr.118.015578_bib502","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/clpt.2012.210","article-title":"The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin","volume":"93","author":"Stocker","year":"2013","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib503","doi-asserted-by":"crossref","first-page":"F767","DOI":"10.1152\/ajprenal.00106.2007","article-title":"Identification of cysteines in rat organic cation transporters rOCT1 (C322, C451) and rOCT2 (C451) critical for transport activity and substrate affinity","volume":"293","author":"Sturm","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib504","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1124\/dmd.110.032763","article-title":"Functional expression of carnitine\/organic cation transporter OCTN1\/SLC22A4 in mouse small intestine and liver","volume":"38","author":"Sugiura","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib505","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nature10354","article-title":"Human metabolic individuality in biomedical and pharmaceutical research","volume":"477","author":"Suhre","year":"2011","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib506","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1124\/mol.104.004713","article-title":"Molecular determinants of substrate\/inhibitor binding to the human and rabbit renal organic cation transporters hOCT2 and rbOCT2","volume":"67","author":"Suhre","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib507","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.pneurobio.2005.04.003","article-title":"Mechanisms of neurotransmitter release by amphetamines: a review","volume":"75","author":"Sulzer","year":"2005","journal-title":"Prog Neurobiol"},{"key":"10.1124\/pr.118.015578_bib508","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/nature11524","article-title":"Crystal structure of a bacterial homologue of glucose transporters GLUT1-4","volume":"490","author":"Sun","year":"2012","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib509","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pnpbp.2013.11.005","article-title":"Inhibition of organic cation transporter 2 and 3 may be involved in the mechanism of the antidepressant-like action of berberine","volume":"49","author":"Sun","year":"2014","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1124\/pr.118.015578_bib510","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1080\/00498254.2018.1542188","article-title":"Jatrorrhizine reduces 5-HT and NE uptake via inhibition of uptake-2 transporters and produces antidepressant-like action in mice","volume":"49","author":"Sun","year":"2019","journal-title":"Xenobiotica"},{"key":"10.1124\/pr.118.015578_bib511","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/cpt.701","article-title":"Genetic polymorphisms in organic cation transporter 1 attenuates hepatic metformin exposure in humans","volume":"102","author":"Sundelin","year":"2017","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib512","doi-asserted-by":"crossref","first-page":"6935","DOI":"10.1093\/hmg\/ddu399","article-title":"Rare mutations associating with serum creatinine and chronic kidney disease","volume":"23","author":"Sveinbjornsson","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.118.015578_bib513","doi-asserted-by":"crossref","first-page":"41611","DOI":"10.1074\/jbc.M108472200","article-title":"Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus","volume":"276","author":"Sweet","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib514","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1254\/jphs.FP0070911","article-title":"Interactions of organic anion transporters and organic cation transporters with mycotoxins","volume":"106","author":"Tachampa","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/pr.118.015578_bib515","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1124\/jpet.105.088104","article-title":"A species difference in the transport activities of H2 receptor antagonists by rat and human renal organic anion and cation transporters","volume":"315","author":"Tahara","year":"2005","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib516","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.108.146449","article-title":"Functional genetic variation in the basal promoter of the organic cation\/carnitine transporters OCTN1 (SLC22A4) and OCTN2 (SLC22A5)","volume":"329","author":"Tahara","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib517","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1016\/j.xphs.2017.05.006","article-title":"Possible role of organic cation transporters in the distribution of [11C]sulpiride, a dopamine D2 receptor antagonist","volume":"106","author":"Takano","year":"2017","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib518","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0005-2736(84)90556-X","article-title":"Carrier-mediated transport systems of tetraethylammonium in rat renal brush-border and basolateral membrane vesicles","volume":"773","author":"Takano","year":"1984","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib519","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1124\/jpet.300.3.918","article-title":"Human organic anion transporters and human organic cation transporters mediate renal antiviral transport","volume":"300","author":"Takeda","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib520","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0005-2736(01)00328-5","article-title":"Na(+)-coupled transport of L-carnitine via high-affinity carnitine transporter OCTN2 and its subcellular localization in kidney","volume":"1512","author":"Tamai","year":"2001","journal-title":"Biochim Biophys Acta"},{"key":"10.1124\/pr.118.015578_bib521","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1021\/mp0340082","article-title":"Involvement of OCTN1 (SLC22A4) in pH-dependent transport of organic cations","volume":"1","author":"Tamai","year":"2004","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib522","doi-asserted-by":"crossref","first-page":"20378","DOI":"10.1074\/jbc.273.32.20378","article-title":"Molecular and functional identification of sodium ion-dependent, high affinity human carnitine transporter OCTN2","volume":"273","author":"Tamai","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib523","doi-asserted-by":"crossref","first-page":"40064","DOI":"10.1074\/jbc.M005340200","article-title":"Molecular and functional characterization of organic cation\/carnitine transporter family in mice","volume":"275","author":"Tamai","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib524","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0014-5793(97)01441-5","article-title":"Cloning and characterization of a novel human pH-dependent organic cation transporter, OCTN1","volume":"419","author":"Tamai","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1124\/pr.118.015578_bib525","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1038\/nature12014","article-title":"Structural basis for the drug extrusion mechanism by a MATE multidrug transporter","volume":"496","author":"Tanaka","year":"2013","journal-title":"Nature"},{"key":"10.1124\/pr.118.015578_bib526","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1093\/hmg\/8.4.655","article-title":"Mutations of OCTN2, an organic cation\/carnitine transporter, lead to deficient cellular carnitine uptake in primary carnitine deficiency","volume":"8","author":"Tang","year":"1999","journal-title":"Hum Mol Genet"},{"key":"10.1124\/pr.118.015578_bib527","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1161\/CIRCRESAHA.116.305360","article-title":"Gut microbiota-dependent trimethylamine N-oxide (TMAO) pathway contributes to both development of renal insufficiency and mortality risk in chronic kidney disease","volume":"116","author":"Tang","year":"2015","journal-title":"Circ Res"},{"key":"10.1124\/pr.118.015578_bib528","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.bcp.2009.06.014","article-title":"Protective effect of concomitant administration of imatinib on cisplatin-induced nephrotoxicity focusing on renal organic cation transporter OCT2","volume":"78","author":"Tanihara","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib529","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.bcp.2007.04.010","article-title":"Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions\/H(+)-organic cation antiporters","volume":"74","author":"Tanihara","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib530","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1289\/ehp.1002839","article-title":"Rotenone, paraquat, and Parkinson\u2019s disease","volume":"119","author":"Tanner","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1124\/pr.118.015578_bib531","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1097\/FPC.0b013e3283561666","article-title":"Association of genetic variation in the organic cation transporters OCT1, OCT2 and multidrug and toxin extrusion 1 transporter protein genes with the gastrointestinal side effects and lower BMI in metformin-treated type 2 diabetes patients","volume":"22","author":"Tarasova","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib532","first-page":"204","article-title":"Organic cation transporter 2 and tumor budding as independent prognostic factors in metastatic colorectal cancer patients treated with oxaliplatin-based chemotherapy","volume":"7","author":"Tatsumi","year":"2013","journal-title":"Int J Clin Exp Pathol"},{"key":"10.1124\/pr.118.015578_bib533","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1136\/gut.2005.076083","article-title":"Functional role of the 503F variant of the organic cation transporter OCTN1 in Crohn\u2019s disease","volume":"54","author":"Taubert","year":"2005","journal-title":"Gut"},{"key":"10.1124\/pr.118.015578_bib534","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1371\/journal.pone.0000385","article-title":"Identification of the endogenous key substrates of the human organic cation transporter OCT2 and their implication in function of dopaminergic neurons","volume":"2","author":"Taubert","year":"2007","journal-title":"PLoS One"},{"key":"10.1124\/pr.118.015578_bib535","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1021\/acs.molpharmaceut.6b00937","article-title":"Identification and characterization of trimethylamine-N-oxide uptake and efflux transporters","volume":"14","author":"Teft","year":"2017","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib536","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1021\/mp400113d","article-title":"Substrate- and cell contact-dependent inhibitor affinity of human organic cation transporter 2: studies with two classical organic cation substrates and the novel substrate cd2+","volume":"10","author":"Th\u00e9venod","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib537","doi-asserted-by":"crossref","first-page":"3739","DOI":"10.1182\/blood-2003-12-4276","article-title":"Active transport of imatinib into and out of cells: implications for drug resistance","volume":"104","author":"Thomas","year":"2004","journal-title":"Blood"},{"key":"10.1124\/pr.118.015578_bib538","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1007\/s00125-007-0771-4","article-title":"High prevalence of low plasma thiamine concentration in diabetes linked to a marker of vascular disease","volume":"50","author":"Thornalley","year":"2007","journal-title":"Diabetologia"},{"key":"10.1124\/pr.118.015578_bib539","first-page":"R1807","article-title":"Fos expression in rat brain during depletion-induced thirst and salt appetite","volume":"274","author":"Thunhorst","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1124\/pr.118.015578_bib540","doi-asserted-by":"crossref","first-page":"475","DOI":"10.2133\/dmpk.24.475","article-title":"Genetic variations of the SLC22A4 gene in Chinese and Indian populations of Singapore","volume":"24","author":"Toh","year":"2009","journal-title":"Drug Metab Pharmacokinet"},{"key":"10.1124\/pr.118.015578_bib541","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/ng1267","article-title":"An intronic SNP in a RUNX1 binding site of SLC22A4, encoding an organic cation transporter, is associated with rheumatoid arthritis","volume":"35","author":"Tokuhiro","year":"2003","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib542","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/ng1935","article-title":"Integrative molecular concept modeling of prostate cancer progression","volume":"39","author":"Tomlins","year":"2007","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib543","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nrn1008","article-title":"Plasma membrane monoamine transporters: structure, regulation and function","volume":"4","author":"Torres","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1124\/pr.118.015578_bib544","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1476-5381.2012.01853.x","article-title":"Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis","volume":"166","author":"Toyama","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1124\/pr.118.015578_bib545","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/FPC.0b013e328335639f","article-title":"Heterozygous variants of multidrug and toxin extrusions (MATE1 and MATE2-K) have little influence on the disposition of metformin in diabetic patients","volume":"20","author":"Toyama","year":"2010","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib546","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.mam.2012.10.011","article-title":"The choline transporter-like family SLC44: properties and roles in human diseases","volume":"34","author":"Traiffort","year":"2013","journal-title":"Mol Aspects Med"},{"key":"10.1124\/pr.118.015578_bib547","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/j.1471-4159.2004.02962.x","article-title":"Molecular characterization of the family of choline transporter-like proteins and their splice variants","volume":"92","author":"Traiffort","year":"2005","journal-title":"J Neurochem"},{"key":"10.1124\/pr.118.015578_bib548","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJM198811173192006","article-title":"Primary carnitine deficiency due to a failure of carnitine transport in kidney, muscle, and fibroblasts","volume":"319","author":"Treem","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1124\/pr.118.015578_bib549","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/ng.314","article-title":"Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease","volume":"41","author":"Tr\u00e9gou\u00ebt","year":"2009","journal-title":"Nat Genet"},{"key":"10.1124\/pr.118.015578_bib550","doi-asserted-by":"crossref","first-page":"10991","DOI":"10.1073\/pnas.0603678103","article-title":"A molecular correlate to the Gleason grading system for prostate adenocarcinoma","volume":"103","author":"True","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib551","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1124\/mol.109.056242","article-title":"Targeted disruption of the multidrug and toxin extrusion 1 (mate1) gene in mice reduces renal secretion of metformin","volume":"75","author":"Tsuda","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib552","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1124\/jpet.108.147918","article-title":"Involvement of human multidrug and toxin extrusion 1 in the drug interaction between cimetidine and metformin in renal epithelial cells","volume":"329","author":"Tsuda","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib553","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tox.2013.06.009","article-title":"Organic cation transporter 1 mediates the uptake of monocrotaline and plays an important role in its hepatotoxicity","volume":"311","author":"Tu","year":"2013","journal-title":"Toxicology"},{"key":"10.1124\/pr.118.015578_bib554","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2125.1981.tb01206.x","article-title":"Metformin kinetics in healthy subjects and in patients with diabetes mellitus","volume":"12","author":"Tucker","year":"1981","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib555","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0027-5107(96)00027-9","article-title":"The mutagenic properties of DNA minor-groove binding ligands","volume":"355","author":"Turner","year":"1996","journal-title":"Mutat Res"},{"key":"10.1124\/pr.118.015578_bib556","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.bcp.2013.06.019","article-title":"Morphine is a substrate of the organic cation transporter OCT1 and polymorphisms in OCT1 gene affect morphine pharmacokinetics after codeine administration","volume":"86","author":"Tzvetkov","year":"2013","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib557","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/cpt.812","article-title":"Increased systemic exposure and stronger cardiovascular and metabolic adverse reactions to fenoterol in individuals with heritable OCT1 deficiency","volume":"103","author":"Tzvetkov","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib558","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/tpj.2010.75","article-title":"Effects of OCT1 polymorphisms on the cellular uptake, plasma concentrations and efficacy of the 5-HT(3) antagonists tropisetron and ondansetron","volume":"12","author":"Tzvetkov","year":"2012","journal-title":"Pharmacogenomics J"},{"key":"10.1124\/pr.118.015578_bib559","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/clpt.2011.56","article-title":"Genetically polymorphic OCT1: another piece in the puzzle of the variable pharmacokinetics and pharmacodynamics of the opioidergic drug tramadol","volume":"90","author":"Tzvetkov","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib560","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/clpt.2009.92","article-title":"The effects of genetic polymorphisms in the organic cation transporters OCT1, OCT2, and OCT3 on the renal clearance of metformin","volume":"86","author":"Tzvetkov","year":"2009","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib561","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/BF00378638","article-title":"Contraluminal transport of organic cations in the proximal tubule of the rat kidney. II. Specificity: anilines, phenylalkylamines (catecholamines), heterocyclic compounds (pyridines, quinolines, acridines)","volume":"420","author":"Ullrich","year":"1992","journal-title":"Pflugers Arch"},{"key":"10.1124\/pr.118.015578_bib562","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00498250701546012","article-title":"Functional involvement of organic cation transporter1 (OCT1\/Oct1) in the hepatic uptake of organic cations in humans and rats","volume":"37","author":"Umehara","year":"2007","journal-title":"Xenobiotica"},{"key":"10.1124\/pr.118.015578_bib563","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/00498250802334409","article-title":"Effect of cationic drugs on the transporting activity of human and rat OCT\/Oct 1-3 in vitro and implications for drug-drug interactions","volume":"38","author":"Umehara","year":"2008","journal-title":"Xenobiotica"},{"key":"10.1124\/pr.118.015578_bib564","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1023\/B:PHAM.0000029286.45788.ad","article-title":"Creatinine transport by basolateral organic cation transporter hOCT2 in the human kidney","volume":"21","author":"Urakami","year":"2004","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib565","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.clpt.6100271","article-title":"Effects of genetic variation in the novel organic cation transporter, OCTN1, on the renal clearance of gabapentin","volume":"83","author":"Urban","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib566","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1124\/mol.106.028126","article-title":"Functional genetic diversity in the high-affinity carnitine transporter OCTN2 (SLC22A5)","volume":"70","author":"Urban","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib567","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/FPC.0b013e3281c6d08e.","article-title":"Functional effects of protein sequence polymorphisms in the organic cation\/ergothioneine transporter OCTN1 (SLC22A4)","volume":"17","author":"Urban","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib568","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/096032718700600107","article-title":"Paraquat poisoning: clinical features and immediate general management","volume":"6","author":"Vale","year":"1987","journal-title":"Hum Toxicol"},{"key":"10.1124\/pr.118.015578_bib569","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0022-3565(25)38917-2","article-title":"Selectivity of the cimetidine-induced alterations in the renal handling of organic substrates in humans: studies with anionic, cationic and zwitterionic drugs","volume":"236","author":"van Crugten","year":"1986","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib570","doi-asserted-by":"crossref","first-page":"12449","DOI":"10.1073\/pnas.1210303109","article-title":"N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB","volume":"109","author":"Van Damme","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib571","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1186\/s12936-017-2062-y","article-title":"Proguanil and cycloguanil are organic cation transporter and multidrug and toxin extrusion substrates","volume":"16","author":"van der Velden","year":"2017","journal-title":"Malar J"},{"key":"10.1124\/pr.118.015578_bib572","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0022-3565(24)29357-5","article-title":"Comparison of \u201ctype I\u201d and \u201ctype II\u201d organic cation transport by organic cation transporters and organic anion-transporting polypeptides","volume":"298","author":"van Montfoort","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib573","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s004399900105","article-title":"Identification of two novel mutations in OCTN2 of three patients with systemic carnitine deficiency","volume":"105","author":"Vaz","year":"1999","journal-title":"Hum Genet"},{"key":"10.1124\/pr.118.015578_bib574","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1042\/bj3610417","article-title":"Carnitine biosynthesis in mammals","volume":"361","author":"Vaz","year":"2002","journal-title":"Biochem J"},{"key":"10.1124\/pr.118.015578_bib575","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1093\/emboj\/20.12.3056","article-title":"The lactose transport protein is a cooperative dimer with two sugar translocation pathways","volume":"20","author":"Veenhoff","year":"2001","journal-title":"EMBO J"},{"key":"10.1124\/pr.118.015578_bib576","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2217\/pgs.14.99","article-title":"ABCC3 and OCT1 genotypes influence pharmacokinetics of morphine in children","volume":"15","author":"Venkatasubramanian","year":"2014","journal-title":"Pharmacogenomics"},{"key":"10.1124\/pr.118.015578_bib577","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1006\/geno.1998.5639","article-title":"Cloning of the mouse and human solute carrier 22a3 (Slc22a3\/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27","volume":"55","author":"Verhaagh","year":"1999","journal-title":"Genomics"},{"key":"10.1124\/pr.118.015578_bib578","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cccn.2005.04.022","article-title":"Laboratory diagnosis of defects of creatine biosynthesis and transport","volume":"361","author":"Verhoeven","year":"2005","journal-title":"Clin Chim Acta"},{"key":"10.1124\/pr.118.015578_bib579","doi-asserted-by":"crossref","first-page":"F1213","DOI":"10.1152\/ajprenal.00068.2006","article-title":"RS1 (RSC1A1) regulates the exocytotic pathway of Na+-D-glucose cotransporter SGLT1","volume":"291","author":"Veyhl","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib580","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00232-003-0626-y","article-title":"Downregulation of the Na(+)- D-glucose cotransporter SGLT1 by protein RS1 (RSC1A1) is dependent on dynamin and protein kinase C","volume":"196","author":"Veyhl","year":"2003","journal-title":"J Membr Biol"},{"key":"10.1124\/pr.118.015578_bib581","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1124\/mol.115.101162","article-title":"Phosphorylation of RS1 (RSC1A1) steers inhibition of different exocytotic pathways for glucose transporter SGLT1 and nucleoside transporter CNT1, and an RS1-derived peptide inhibits glucose absorption","volume":"89","author":"Veyhl-Wichmann","year":"2016","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib582","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.1523\/JNEUROSCI.5147-03.2004","article-title":"Organic cation transporter 3 (Slc22a3) is implicated in salt-intake regulation","volume":"24","author":"Vialou","year":"2004","journal-title":"J Neurosci"},{"key":"10.1124\/pr.118.015578_bib583","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1471-4159.2008.05506.x","article-title":"Altered aminergic neurotransmission in the brain of organic cation transporter 3-deficient mice","volume":"106","author":"Vialou","year":"2008","journal-title":"J Neurochem"},{"key":"10.1124\/pr.118.015578_bib584","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1124\/dmd.117.077248","article-title":"Colistin is substrate of the carnitine\/organic cation transporter 2 (OCTN2, SLC22A5)","volume":"45","author":"Visentin","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib585","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/dmd.118.081091","article-title":"Fluorocholine transport mediated by the organic cation transporter 2 (OCT2, SLC22A2): implication for imaging of kidney tumors","volume":"46","author":"Visentin","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib586","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1124\/dmd.116.072371","article-title":"Impact of organic cation transporters (OCT-SLC22A) on differential diagnosis of intrahepatic lesions","volume":"45","author":"Visentin","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib587","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1124\/mol.64.5.1037","article-title":"Different affinities of inhibitors to the outwardly and inwardly directed substrate binding site of organic cation transporter 2","volume":"64","author":"Volk","year":"2003","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib588","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1124\/mol.109.054783","article-title":"Five amino acids in the innermost cavity of the substrate binding cleft of organic cation transporter 1 interact with extracellular and intracellular corticosterone","volume":"76","author":"Volk","year":"2009","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib589","doi-asserted-by":"crossref","first-page":"F584","DOI":"10.1152\/ajprenal.2000.279.3.F584","article-title":"Functional and pharmacological characterization of human Na(+)-carnitine cotransporter hOCTN2","volume":"279","author":"Wagner","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib590","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1124\/dmd.116.074708","article-title":"Interaction and transport of methamphetamine and its primary metabolites by organic cation and multidrug and toxin extrusion transporters","volume":"45","author":"Wagner","year":"2017","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib591","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1124\/dmd.118.082131","article-title":"Disposition of methamphetamine and major metabolites in mice: role of organic cation transporter 3 in tissue-selective accumulation of para-hydroxymethamphetamine","volume":"46","author":"Wagner","year":"2018","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib592","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/gut.2005.084574","article-title":"Evidence for association of OCTN genes and IBD5 with ulcerative colitis","volume":"55","author":"Waller","year":"2006","journal-title":"Gut"},{"key":"10.1124\/pr.118.015578_bib593","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10549-011-1925-0","article-title":"SLC22A5\/OCTN2 expression in breast cancer is induced by estrogen via a novel intronic estrogen-response element (ERE)","volume":"134","author":"Wang","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1124\/pr.118.015578_bib594","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1124\/pr.118.015578_bib595","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1124\/jpet.102.034140","article-title":"Involvement of organic cation transporter 1 in hepatic and intestinal distribution of metformin","volume":"302","author":"Wang","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib596","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/sj.clpt.6100268","article-title":"Expression of the uptake drug transporter hOCT1 is an important clinical determinant of the response to imatinib in chronic myeloid leukemia","volume":"83","author":"Wang","year":"2008","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib597","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/j.1745-7270.2007.00323.x","article-title":"Choline transporters in human lung adenocarcinoma: expression and functional implications","volume":"39","author":"Wang","year":"2007","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"10.1124\/pr.118.015578_bib598","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.taap.2018.11.007","article-title":"Clozapine-induced reduction of l-carnitine reabsorption via inhibition\/down-regulation of renal carnitine\/organic cation transporter 2 contributes to liver lipid metabolic disorder in mice","volume":"363","author":"Wang","year":"2019","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1124\/pr.118.015578_bib599","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/(SICI)1098-1004(200003)15:3<238::AID-HUMU4>3.0.CO;2-3","article-title":"A missense mutation in the OCTN2 gene associated with residual carnitine transport activity","volume":"15","author":"Wang","year":"2000","journal-title":"Hum Mutat"},{"key":"10.1124\/pr.118.015578_bib600","doi-asserted-by":"crossref","first-page":"20782","DOI":"10.1074\/jbc.M000194200","article-title":"Abnormal sodium stimulation of carnitine transport in primary carnitine deficiency","volume":"275","author":"Wang","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib601","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1073\/pnas.96.5.2356","article-title":"Mutations in the organic cation\/carnitine transporter OCTN2 in primary carnitine deficiency","volume":"96","author":"Wang","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1124\/pr.118.015578_bib602","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1097\/FPC.0b013e328302cd41","article-title":"OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine","volume":"18","author":"Wang","year":"2008","journal-title":"Pharmacogenet Genomics"},{"key":"10.1124\/pr.118.015578_bib603","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1038\/leu.2015.170","article-title":"OCT1 and imatinib transport in CML: is it clinically relevant?","volume":"29","author":"Watkins","year":"2015","journal-title":"Leukemia"},{"key":"10.1124\/pr.118.015578_bib604","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1365-2125.1987.tb03245.x","article-title":"Single dose pharmacokinetics of proguanil and its metabolites in healthy subjects","volume":"24","author":"Wattanagoon","year":"1987","journal-title":"Br J Clin Pharmacol"},{"key":"10.1124\/pr.118.015578_bib605","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jphs.2016.01.001","article-title":"Transport of 3-fluoro-L-\u03b1-methyl-tyrosine (FAMT) by organic ion transporters explains renal background in [(18)F]FAMT positron emission tomography","volume":"130","author":"Wei","year":"2016","journal-title":"J Pharmacol Sci"},{"key":"10.1124\/pr.118.015578_bib606","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s00210-010-0590-x","article-title":"Oxybutynin and trospium are substrates of the human organic cation transporters","volume":"383","author":"Wenge","year":"2011","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.118.015578_bib607","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1093\/rheumatology\/kei009","article-title":"RUNX1 intronic SNP is not associated with rheumatoid arthritis susceptibility in Dutch Caucasians","volume":"44","author":"Wesoly","year":"2005","journal-title":"Rheumatology (Oxford)"},{"key":"10.1124\/pr.118.015578_bib608","doi-asserted-by":"crossref","first-page":"4064","DOI":"10.1182\/blood-2007-06-093617","article-title":"Most CML patients who have a suboptimal response to imatinib have low OCT-1 activity: higher doses of imatinib may overcome the negative impact of low OCT-1 activity","volume":"110","author":"White","year":"2007","journal-title":"Blood"},{"key":"10.1124\/pr.118.015578_bib610","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/00498259409043220","article-title":"Accumulation of metformin by tissues of the normal and diabetic mouse","volume":"24","author":"Wilcock","year":"1994","journal-title":"Xenobiotica"},{"key":"10.1124\/pr.118.015578_bib611","first-page":"1337","article-title":"Relative carnitine insufficiency in children with type I diabetes mellitus","volume":"143","author":"Winter","year":"1989","journal-title":"Am J Dis Child"},{"key":"10.1124\/pr.118.015578_bib612","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1021\/jm301302s","article-title":"Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling","volume":"56","author":"Wittwer","year":"2013","journal-title":"J Med Chem"},{"key":"10.1124\/pr.118.015578_bib613","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/19440049.2011.563370","article-title":"Present and future directions of translational research on aflatoxin and hepatocellular carcinoma: a review","volume":"29","author":"Wogan","year":"2012","journal-title":"Food Addit Contam Part A Chem Anal Control Expo Risk Assess"},{"key":"10.1124\/pr.118.015578_bib614","doi-asserted-by":"crossref","first-page":"F449","DOI":"10.1152\/ajprenal.2000.279.3.F449","article-title":"Structure, function, and regional distribution of the organic cation transporter OCT3 in the kidney","volume":"279","author":"Wu","year":"2000","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib615","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0022-3565(24)35056-6","article-title":"Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation\/carnitine transporter","volume":"290","author":"Wu","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib616","doi-asserted-by":"crossref","first-page":"32776","DOI":"10.1074\/jbc.273.49.32776","article-title":"Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain","volume":"273","author":"Wu","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib617","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1006\/bbrc.1998.8669","article-title":"cDNA sequence, transport function, and genomic organization of human OCTN2, a new member of the organic cation transporter family","volume":"246","author":"Wu","year":"1998","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib618","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s00702-009-0205-1","article-title":"Decreased anxiety in mice lacking the organic cation transporter 3","volume":"116","author":"Wultsch","year":"2009","journal-title":"J Neural Transm (Vienna)"},{"key":"10.1124\/pr.118.015578_bib619","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s11095-018-2445-y","article-title":"Fampridine is a substrate and inhibitor of human OCT2, but not of human MATE1, or MATE2K","volume":"35","author":"Xiao","year":"2018","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib620","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1021\/mp400423g","article-title":"Combinatorial pharmacophore modeling of organic cation transporter 2 (OCT2) inhibitors: insights into multiple inhibitory mechanisms","volume":"10","author":"Xu","year":"2013","journal-title":"Mol Pharm"},{"key":"10.1124\/pr.118.015578_bib621","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-291X(03)00930-6","article-title":"Characterization of organic cation\/carnitine transporter family in human sperm","volume":"306","author":"Xuan","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1124\/pr.118.015578_bib622","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S0022-3565(24)38199-6","article-title":"Novel membrane transporter OCTN1 mediates multispecific, bidirectional, and pH-dependent transport of organic cations","volume":"289","author":"Yabuuchi","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib623","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tibs.2013.01.003","article-title":"Structural advances for the major facilitator superfamily (MFS) transporters","volume":"38","author":"Yan","year":"2013","journal-title":"Trends Biochem Sci"},{"key":"10.1124\/pr.118.015578_bib624","doi-asserted-by":"crossref","first-page":"6260","DOI":"10.1128\/AAC.00986-16","article-title":"Multiple drug transporters are involved in renal secretion of entecavir","volume":"60","author":"Yang","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.118.015578_bib625","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.clpt.2004.08.026","article-title":"Different effects of three transporting inhibitors, verapamil, cimetidine, and probenecid, on fexofenadine pharmacokinetics","volume":"77","author":"Yasui-Furukori","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib626","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1002\/jps.22548","article-title":"Characterization of human OCT1-mediated transport of DAPI as a fluorescent probe substrate","volume":"100","author":"Yasujima","year":"2011","journal-title":"J Pharm Sci"},{"key":"10.1124\/pr.118.015578_bib627","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1124\/dmd.109.030221","article-title":"Evaluation of 4',6-diamidino-2-phenylindole as a fluorescent probe substrate for rapid assays of the functionality of human multidrug and toxin extrusion proteins","volume":"38","author":"Yasujima","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib628","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/cpt.1098","article-title":"Influence of transporter polymorphisms on drug disposition and response: a perspective from the international transporter consortium","volume":"104","author":"Yee","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib629","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1124\/jpet.116.236158","article-title":"Impact of substrate-dependent inhibition on renal organic cation transporters hOCT2 and hMATE1\/2-K-mediated drug transport and intracellular accumulation","volume":"359","author":"Yin","year":"2016","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib630","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1126\/science.1125629","article-title":"Structure of the multidrug transporter EmrD from Escherichia coli","volume":"312","author":"Yin","year":"2006","journal-title":"Science"},{"key":"10.1124\/pr.118.015578_bib631","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1124\/dmd.108.023168","article-title":"Significance of OCT3\/SLC22A3, organic cation transporter 3, expression for the cytotoxic effect of oxaliplatin in colorectal cancer","volume":"36","author":"Yokoo","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib632","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.bcp.2007.03.004","article-title":"Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity","volume":"74","author":"Yokoo","year":"2007","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib633","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/j.bcp.2005.09.020","article-title":"Association between tubular toxicity of cisplatin and expression of organic cation transporter rOCT2 (Slc22a2) in the rat","volume":"70","author":"Yonezawa","year":"2005","journal-title":"Biochem Pharmacol"},{"key":"10.1124\/pr.118.015578_bib634","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1124\/jpet.106.110346","article-title":"Cisplatin and oxaliplatin, but not carboplatin and nedaplatin, are substrates for human organic cation transporters (SLC22A1-3 and multidrug and toxin extrusion family)","volume":"319","author":"Yonezawa","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib635","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1208\/s12248-013-9460-z","article-title":"Influences of organic cation transporter polymorphisms on the population pharmacokinetics of metformin in healthy subjects","volume":"15","author":"Yoon","year":"2013","journal-title":"AAPS J"},{"key":"10.1124\/pr.118.015578_bib636","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/cpt.941","article-title":"Emerging clinical importance of hepatic organic cation transporter 1 (OCT1) in drug pharmacokinetics, dynamics, pharmacogenetic variability, and drug Interactions","volume":"103","author":"Zamek-Gliszczynski","year":"2018","journal-title":"Clin Pharmacol Ther"},{"key":"10.1124\/pr.118.015578_bib637","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0899-9007(00)00349-X","article-title":"Choline: an essential nutrient for humans","volume":"16","author":"Zeisel","year":"2000","journal-title":"Nutrition"},{"key":"10.1124\/pr.118.015578_bib638","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1146\/annurev.nu.14.070194.001413","article-title":"Choline and human nutrition","volume":"14","author":"Zeisel","year":"1994","journal-title":"Annu Rev Nutr"},{"issue":"8","key":"10.1124\/pr.118.015578_bib639","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00199-19","article-title":"Multiple Drug Transporters Contribute to the Placental Transfer of Emtricitabine","volume":"63","author":"Zeng","year":"2019","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1124\/pr.118.015578_bib640","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1124\/mol.51.6.913","article-title":"Cloning and functional expression of a human liver organic cation transporter","volume":"51","author":"Zhang","year":"1997","journal-title":"Mol Pharmacol"},{"key":"10.1124\/pr.118.015578_bib641","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0090-9556(24)15369-X","article-title":"Interactions of HIV protease inhibitors with a human organic cation transporter in a mammalian expression system","volume":"28","author":"Zhang","year":"2000","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib642","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/S0022-3565(24)37595-0","article-title":"Functional characterization of an organic cation transporter (hOCT1) in a transiently transfected human cell line (HeLa)","volume":"286","author":"Zhang","year":"1998","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1124\/pr.118.015578_bib643","doi-asserted-by":"crossref","first-page":"8847","DOI":"10.1158\/0008-5472.CAN-06-0769","article-title":"Organic cation transporters are determinants of oxaliplatin cytotoxicity","volume":"66","author":"Zhang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1124\/pr.118.015578_bib644","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1124\/dmd.108.021121","article-title":"Drug transporter and cytochrome P450 mRNA expression in human ocular barriers: implications for ocular drug disposition","volume":"36","author":"Zhang","year":"2008","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib645","doi-asserted-by":"crossref","first-page":"27971","DOI":"10.1074\/jbc.M112.386979","article-title":"Twelve transmembrane helices form the functional core of mammalian MATE1 (multidrug and toxin extruder 1) protein","volume":"287","author":"Zhang","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib646","doi-asserted-by":"crossref","first-page":"34813","DOI":"10.1074\/jbc.M506342200","article-title":"A conserved glutamate residue in transmembrane helix 10 influences substrate specificity of rabbit OCT2 (SLC22A2)","volume":"280","author":"Zhang","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1124\/pr.118.015578_bib647","doi-asserted-by":"crossref","first-page":"F263","DOI":"10.1152\/ajprenal.00123.2009","article-title":"MATE1 has an external COOH terminus, consistent with a 13-helix topology","volume":"297","author":"Zhang","year":"2009","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1124\/pr.118.015578_bib648","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000336244","article-title":"Correlation between imatinib trough concentration and efficacy in Chinese chronic myelocytic leukemia patients","volume":"127","author":"Zhong","year":"2012","journal-title":"Acta Haematol"},{"key":"10.1124\/pr.118.015578_bib649","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1172\/JCI13505","article-title":"Role of AMP-activated protein kinase in mechanism of metformin action","volume":"108","author":"Zhou","year":"2001","journal-title":"J Clin Invest"},{"key":"10.1124\/pr.118.015578_bib650","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.2337\/db08-0896","article-title":"Reduced-function SLC22A1 polymorphisms encoding organic cation transporter 1 and glycemic response to metformin: a GoDARTS study","volume":"58","author":"Zhou","year":"2009","journal-title":"Diabetes"},{"key":"10.1124\/pr.118.015578_bib651","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1124\/dmd.107.015495","article-title":"Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine","volume":"35","author":"Zhou","year":"2007","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib652","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1471-4159.2010.06738.x","article-title":"Interaction of organic cation transporter 3 (SLC22A3) and amphetamine","volume":"114","author":"Zhu","year":"2010","journal-title":"J Neurochem"},{"key":"10.1124\/pr.118.015578_bib653","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s11095-018-2526-y","article-title":"Irinotecan alters the disposition of morphine via inhibition of organic cation transporter 1 (OCT1) and 2 (OCT2)","volume":"35","author":"Zhu","year":"2018","journal-title":"Pharm Res"},{"key":"10.1124\/pr.118.015578_bib654","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1124\/dmd.108.023762","article-title":"Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser","volume":"37","author":"Zolk","year":"2009","journal-title":"Drug Metab Dispos"},{"key":"10.1124\/pr.118.015578_bib655","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00210-008-0369-5","article-title":"Structural determinants of inhibitor interaction with the human organic cation transporter OCT2 (SLC22A2)","volume":"379","author":"Zolk","year":"2009","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1124\/pr.118.015578_bib656","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1101\/gad.206201","article-title":"Bidirectional action of the Igf2r imprint control element on upstream and downstream imprinted genes","volume":"15","author":"Zwart","year":"2001","journal-title":"Genes Dev"},{"key":"10.1124\/pr.118.015578_bib657","doi-asserted-by":"crossref","first-page":"4188","DOI":"10.1128\/MCB.21.13.4188-4196.2001","article-title":"Impaired activity of the extraneuronal monoamine transporter system known as uptake-2 in Orct3\/Slc22a3-deficient mice","volume":"21","author":"Zwart","year":"2001","journal-title":"Mol Cell Biol"}],"container-title":["Pharmacological Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724009463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031699724009463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1124\/pr.118.015578","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T05:04:40Z","timestamp":1739855080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031699724009463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":653,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S0031699724009463"],"URL":"https:\/\/doi.org\/10.1124\/pr.118.015578","relation":{},"ISSN":["0031-6997"],"issn-type":[{"value":"0031-6997","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Organic Cation Transporters in Health and Disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1124\/pr.118.015578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 by The American Society for Pharmacology and Experimental Therapeutics","name":"copyright","label":"Copyright"}]}}